<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Management of asymptomatic abdominal aortic aneurysm</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Management of asymptomatic abdominal aortic aneurysm</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Management of asymptomatic abdominal aortic aneurysm</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Ronald L Dalman, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Matthew Mell, MD, MS, FACS</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joseph L Mills, Sr, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">John F Eidt, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Denis L Clement, MD, PhD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Mark A Creager, MD, FAHA, FACC, MSVM</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Kathryn A Collins, MD, PhD, FACS</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 03, 2024.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H611107773"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Abdominal aortic aneurysm (AAA) is a common and potentially life-threatening condition. Without repair, ruptured AAA is nearly uniformly fatal. Of the 50 percent of patients with ruptured AAA who reach the hospital for treatment, between 30 and 50 percent will die in the hospital [<a href="#rid1">1,2</a>]. </p><p>For asymptomatic patients, elective repair of the aneurysm is the most effective management to prevent rupture. However, elective aortic surgery is also associated with risks, and thus, elective AAA repair is not recommended until the risk of rupture exceeds the risks associated with repair. For asymptomatic patients, the risk of AAA rupture generally exceeds the risk associated with elective AAA repair when aneurysm diameter exceeds 5.5 cm [<a href="#rid3">3,4</a>]. Other factors such as the patient's age, rate of aneurysm expansion, and the presence of coexistent peripheral artery disease or peripheral aneurysm are also important to consider when determining when to proceed with elective AAA repair. </p><p>For patients with asymptomatic AAA who do not have indications for elective repair, medical treatment is aimed at reducing the risk for future cardiovascular events and limiting the rate of aortic expansion. When elective AAA repair is indicated, the choice between open and endovascular AAA repair is based on anatomic factors, and patient and surgeon preference. Although elective endovascular AAA repair is associated with lower rates of perioperative (30-day) morbidity and mortality compared with elective open repair (&lt;2 versus approximately 5 percent), long-term outcomes are similar [<a href="#rid5">5-7</a>]. </p><p>The management of the patient with asymptomatic AAA will be reviewed here. The clinical features and issues related to diagnosis and screening, management of symptomatic (nonruptured) and ruptured AAA, and details of surgical and endovascular repair are discussed separately.</p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/7569.html" rel="external">"Screening for abdominal aortic aneurysm"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm"</a> and  <a class="medical medical_review" href="/z/d/html/16843.html" rel="external">"Surgical and endovascular repair of ruptured abdominal aortic aneurysm"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>(See  <a class="medical medical_review" href="/z/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm"</a> and  <a class="medical medical_review" href="/z/d/html/15189.html" rel="external">"Open surgical repair of abdominal aortic aneurysm"</a>.)</p><p></p><p class="headingAnchor" id="H611107780"><span class="h1">ANEURYSM TERMINOLOGY</span></p><p class="headingAnchor" id="H185925562"><span class="h2">Aneurysm definition</span><span class="headingEndMark"> — </span>An abdominal aorta with a maximal diameter &gt;3.0 cm is considered aneurysmal in most adult patients [<a href="#rid3">3,4,8,9</a>]. Abdominal aortic aneurysm (AAA) most often affects the segment of aorta between the renal and inferior mesenteric arteries (infrarenal)  (<a class="graphic graphic_figure graphicRef60682" href="/z/d/graphic/60682.html" rel="external">figure 1</a>); approximately 5 percent involve the renal (pararenal)  (<a class="graphic graphic_diagnosticimage graphicRef87567" href="/z/d/graphic/87567.html" rel="external">image 1</a>) or visceral arteries (suprarenal) [<a href="#rid10">10</a>]. (See  <a class="medical medical_review" href="/z/d/html/87283.html" rel="external">"Overview of abdominal aortic aneurysm", section on 'Definitions and aortoiliac anatomy'</a>.)</p><p>For the purposes of this discussion:</p><p class="bulletIndent1"><span class="glyph">●</span>Small aneurysms have a diameter &lt;4.0 cm</p><p class="bulletIndent1"><span class="glyph">●</span>Medium aneurysms have a diameter between 4.0 and 5.5 cm</p><p class="bulletIndent1"><span class="glyph">●</span>Large aneurysms have a diameter ≥5.5 cm</p><p class="bulletIndent1"><span class="glyph">●</span>Very large aneurysms have a diameter ≥6.0 cm</p><p></p><p>Rapid expansion, which is thought to increase the risk for rupture, is defined as an increase in maximal aortic diameter ≥5 mm over a six-month period of time or &gt;10 mm over one year, using the same radiographic method of measurement [<a href="#rid4">4</a>]. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.)</p><p class="headingAnchor" id="H933032628"><span class="h2">Clinical presentations</span><span class="headingEndMark"> — </span>Most AAAs do not produce any symptoms. An occult AAA might be discovered as a result of screening, on routine physical examination, or on imaging studies obtained to evaluate an unrelated condition. Symptomatic AAA refers to any of a number of symptoms (eg, abdominal pain, limb ischemia) that can be attributed to the aneurysm. Symptoms associated with AAA may or may not be due to AAA rupture. The clinical features and diagnosis of AAA and the management of symptomatic (nonruptured) and ruptured AAA are discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Clinical presentations'</a> and  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Symptoms'</a>.)</p><p class="headingAnchor" id="H1191820574"><span class="h1">ANEURYSM REPAIR VERSUS CONSERVATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Elective abdominal aortic aneurysm (AAA) repair is the most effective management to prevent rupture. However, elective aortic surgery is associated with risks, and thus, elective AAA repair is not recommended until the risk of rupture exceeds the risks associated with repair (anesthetic risk, technique-related risks) [<a href="#rid6">6,7,11</a>]. For asymptomatic patients, randomized trials comparing observation with open or endovascular AAA repair have found that the risk of AAA rupture generally does not exceed the risk associated with elective AAA repair until aneurysm diameter exceeds 5.5 cm  (<a class="graphic graphic_algorithm graphicRef131024" href="/z/d/graphic/131024.html" rel="external">algorithm 1</a>) [<a href="#rid12">12-16</a>]. We agree with guidelines from the Society for Vascular Surgery that recommend observation for asymptomatic AAA &lt;5.5 cm in diameter based upon these trials [<a href="#rid7">7,17</a>]. (See <a class="local">'Aneurysm diameter and rupture risk'</a> below.)</p><p>The timing of AAA repair may be affected by other factors such as the presence of coexistent peripheral artery disease or peripheral aneurysm (eg, iliac aneurysm, femoral aneurysm) and other factors that increase the risk of rupture, including advanced age and rapid aneurysm expansion. (See <a class="local">'Other considerations'</a> below.)</p><p>Although repair may not be warranted in patients with AAA diameter &lt;5.5 cm, these patients remain at risk for aneurysm expansion. As such, management consists of ongoing clinical evaluation and AAA surveillance, and risk modification. (See <a class="local">'Conservative management'</a> below.)</p><p class="headingAnchor" id="H431203144"><span class="h2">Aneurysm diameter and rupture risk</span><span class="headingEndMark"> — </span>Rupture is the most feared complication and is associated with high morbidity and mortality. Aneurysm diameter is the strongest predictor of aneurysm rupture, with risk increasing markedly at aneurysm diameters greater than 5.5 cm  (<a class="graphic graphic_figure graphicRef57275" href="/z/d/graphic/57275.html" rel="external">figure 2</a>) [<a href="#rid12">12,18-25</a>]. Larger aneurysm diameter and faster rate of aneurysm expansion correlate to an increased likelihood of symptoms and complications. While it is uncommon for AAAs smaller than 5 cm to rupture, it does happen [<a href="#rid26">26,27</a>]. As an example, in one systematic review that included 21 studies of patients with AAA also reporting AAA outcomes, 37 of 2323 (1.6 percent) with AAA between 3.0 and 5.4 cm went on to rupture [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.)</p><p class="headingAnchor" id="H3586739"><span class="h3">Randomized trials</span><span class="headingEndMark"> — </span>Based upon observational studies of the natural history of AAA showing that it was uncommon for asymptomatic AAA smaller than 5 cm to rupture, this was the traditional threshold above which open aneurysm repair was performed [<a href="#rid27">27,29</a>]. Whether this represented optimal management was addressed in randomized trials comparing aneurysm repair with nonoperative management plus surveillance imaging for medium-sized aneurysms (4.0 to 5.5 cm), with two trials using open AAA repair [<a href="#rid12">12,13</a>], and three later trials using endovascular aneurysm repair [<a href="#rid14">14-16,30,31</a>]. These trials and a subsequent meta-analysis found no advantage to early repair (open or endovascular) for AAA measuring 4.0 to 5.5 cm [<a href="#rid32">32</a>]. </p><p class="headingAnchor" id="H3586232"><span class="h4">Observation versus open repair</span><span class="headingEndMark"> — </span>In the United Kingdom (UK) Small Aneurysm and (US) Aneurysm Detection and Management (ADAM) trials, which were predominantly composed of men, the risk of death due to rupture during the period of surveillance of medium-sized (4.0 to 4.4 cm) AAA was lower than the risk of death from open AAA repair [<a href="#rid12">12,13,33</a>]. A later analysis pooled results from both trials and reported no differences in survival between immediate open repair and surveillance (2.6- to 8-year follow-up) for any diameter in the range of 4 to 5.5 cm, for males or females, or for any age [<a href="#rid34">34</a>]. </p><p>The important points of these trials are summarized: </p><p class="bulletIndent1"><span class="glyph">●</span>UK Small Aneurysm trial – The UK Small Aneurysm trial randomly assigned 1090 patients (83 percent men) with asymptomatic AAA with a diameter of 4.0 to 5.5 cm to elective surgery or observation with ultrasound surveillance every six months [<a href="#rid12">12,33,35,36</a>]. Open surgical repair was performed if the aneurysm diameter exceeded 5.5 cm, expanded more than 10 mm in a year, or became tender or symptomatic. The two groups had similar cardiovascular risk factors at baseline. After a mean follow-up of eight years, the following findings were noted:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>An initial survival advantage was apparent for patients in the observation group because of a 30-day operative mortality of 5.4 percent. However, at eight-year follow-up, mortality was significantly lower for patients who underwent elective surgery (43 versus 48 percent). Equipoise between the therapies was achieved at approximately five years  (<a class="graphic graphic_figure graphicRef76015" href="/z/d/graphic/76015.html" rel="external">figure 3</a>) (the point at which the area under the survival curve is equal).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The mean duration of survival was the same in the two groups (6.7 versus 6.5 years) since early mortality was offset by improved late survival in the group that underwent surgery. The authors ascribe the improved late survival in the surgery group to beneficial changes in lifestyle, particularly smoking cessation, which was more frequent in this group. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>During follow-up of the surveillance group, the median aneurysm growth rate was 3.3 mm per year and the mean risk of aneurysm rupture was 1.6 percent per year during the initial follow-up period but increased to 3.2 percent per year during the last three years of follow-up, as expected, since the aneurysms under surveillance were larger during this later time period. </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The risk of AAA rupture was four times higher in females compared with males (hazard ratio [HR] 4.0, 95% CI 2.0-7.9). The incidence of fatal rupture was also significantly greater for females compared with males (19 versus 14 percent). (See <a class="local">'Female sex'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>ADAM trial – The Aneurysm Detection and Management (ADAM) Trial randomly assigned 1136 patients (over 99 percent male) aged 50 to 79 years with AAA diameter between 4.0 to 5.4 cm to open aneurysm repair or surveillance [<a href="#rid13">13</a>]. Elective surgery was performed when the aneurysm expanded to &gt;5.5 cm or became symptomatic. Operative mortality in this trial was 2.7 percent. After 4.9 years of follow-up, there were no differences in mortality (25 versus 21.5 percent) or aneurysm-related death (3 versus 2.6 percent) between the surgery and surveillance groups. In the surveillance arm, 62 percent of the patients eventually required surgery. AAA rupture occurred in 1.9 percent (0.6 percent per year).</p><p></p><p class="headingAnchor" id="H3586239"><span class="h4">Observation versus endovascular repair</span><span class="headingEndMark"> — </span>The UK Small Aneurysm Trial and the ADAM trial were performed prior to the widespread use of endovascular aneurysm repair (EVAR). Trials comparing EVAR to observation for AAA &lt;5.5 cm similarly have found no significant mortality benefit for AAA repair (EVAR) and nonoperative management, and these studies lend further support to the 5.5 cm threshold established from earlier randomized trials [<a href="#rid14">14-16,30,31,37-39</a>]. Despite the lower perioperative mortality rate associated with EVAR, there appears to be no advantage to elective EVAR repair for small and medium-sized aneurysms.</p><p class="headingAnchor" id="H1205369074"><span class="h3">Large observational studies</span><span class="headingEndMark"> — </span>In large observational studies of individuals identified as having small or medium sized AAA as a result of participation in screening studies and followed with surveillance ultrasound, the overall risk of AAA rupture was low [<a href="#rid40">40</a>]. In a review of males older than 65 in the National Health Service AAA Screening Programme in the United Kingdom, 1846/18,652 (10 percent) of the males met criteria for referral for AAA repair during the surveillance period because AAA diameter exceeded 5.5 cm or for other reasons (eg, associated iliac aneurysm, tenderness, rapid expansion) [<a href="#rid40">40</a>]. The overall rate of rupture was very low at 0.17 percent (31 of 18,652); however, most males (29/31) who presented with ruptured small or medium diameter aneurysms died.</p><p class="headingAnchor" id="H3585400"><span class="h2">Other considerations</span><span class="headingEndMark"> — </span>A decision for elective repair of asymptomatic AAA relies primarily on determining rupture risk based upon aneurysm diameter &gt;5.5 cm. However, the diameter threshold for repair is not absolute. Deciding when to perform elective AAA repair should also account for the natural history of AAA and factors that increase the risk for aneurysm expansion or rupture such as female sex, advanced age, expansion rates, and aneurysm morphology. Timing of AAA repair may also be affected by coexistent vascular disease or other peripheral artery aneurysms. These issues are reviewed below. Additional information regarding risk factors associated with AAA expansion and rupture can be found in the linked topic. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.)</p><p>Some studies have also identified disparities in rupture rates based upon insurance status [<a href="#rid41">41,42</a>]. Differences are multifactorial but can be explained in part by lower surveillance rates for patients with known AAA for patients eligible for Medicaid insurance. This finding highlights the need for and value of surveillance for all patients with AAA that does not meet criteria for operative repair, preferably using a standardized protocol. (See <a class="local">'Follow-up and surveillance'</a> below.)</p><p class="headingAnchor" id="H3585407"><span class="h3">Female sex</span><span class="headingEndMark"> — </span>Differences in demographics, natural history, and outcomes have raised interest in better defining the value that determines the presence of AAA in females and, furthermore, the ideal threshold for repair. Randomized trials that have determined these values, as discussed above, are comprised predominately of male subjects. (See <a class="local">'Randomized trials'</a> above.)</p><p>For females, a lower threshold of 5 cm may be justified for elective repair of asymptomatic AAA due to the higher rate of rupture in females compared with males for AAA of the same diameter [<a href="#rid12">12,17,43,44</a>]. Using a smaller diameter of aorta as the threshold for diagnosis would alter the commonly cited prevalence of AAA for females [<a href="#rid45">45</a>] and might improve the likelihood of females being offered repair. Moreover, the proportion of females who meet all eligibility criteria for endovascular repair related to anatomy may decrease as aortic diameter increases [<a href="#rid46">46-48</a>]. However, the impact of this on overall survival is less certain. Perioperative mortality with AAA repair is higher using current indications for repair, and as a result, females may be more likely to die from early intervention than from rupture during ongoing surveillance [<a href="#rid49">49-54</a>]. On the other hand, mortality following repair of AAA at a lower threshold diameter is unknown. It may be similar or worse, or possibly improved if such patients are more medically fit with more favorable anatomy at the time of repair. </p><p>Based on the studies below and others, a reasonable compromise may be to offer AAA repair at the lower threshold of 5.0 cm to females who are at low operative risk, while using the typical threshold for females who have a higher operative risk [<a href="#rid49">49,55-59</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>In a systematic review comparing AAA in females with males, a higher proportion of females were not offered intervention (34 versus 19 percent; odds ratio [OR] 2.3, 95% CI 1.2-4.2, four studies), a smaller proportion of females were considered eligible for endovascular repair (34 versus 54 percent; OR 0.44, 95% CI 0.32-0.62, five studies), and, when repair was performed, operative mortality was higher for females regardless of the method of repair (EVAR: 2.3 versus 1.4 percent; OR 1.7, 95% CI 1.4-2.0; open repair: 5.4 versus 2.8 percent, OR 1.8, 95% CI 1.4-2.3, nine studies) [<a href="#rid55">55</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a review of 4045 patients from the Vascular Study Group of New England (VSGNE) database that included 890 females, aneurysm diameter alone was most predictive of rupture for men, whereas for females, aortic size index (ASI = aneurysm diameter [cm]/body surface area [m<sup>2</sup>]) was predictive (ASI &gt;3.5-3.9: OR 6.4, 95% CI 1.7-24.1; ASI ≥4.0: OR 9.5, 95% CI 2.3-39.4) [<a href="#rid56">56</a>]. However, the risk of death from elective repair was also increased for females, in part related to a later age at presentation. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A follow-up study compared survival differences between those with AAA 4.0 to 5.4 cm undergoing immediate open repair versus surveillance among participants of the UK Small Aneurysm Trial and the ADAM trials (n = 2226) [<a href="#rid53">53</a>]. Survival was similar for both females and males independent of treatment (open repair or surveillance). Survival for females was also similar for moderate-size AAA (5.0 to 5.4 cm) versus smaller (&lt;4.0 to 5 cm) aneurysms. Using a risk-adjusted model, the risk-adjusted survival probability following repair was higher when the aneurysm reached or exceeded 5 cm. </p><p></p><p class="headingAnchor" id="H3585414"><span class="h3">Patient age</span><span class="headingEndMark"> — </span>Younger patients with AAA with a long life expectancy will likely require repair at some point in their lives [<a href="#rid12">12</a>]. The likelihood of receiving surgery at some point in the future for medium-sized aneurysms (4.0 to 5.5 cm), is 50 percent at three years, 60 to 65 percent at five years, and 70 to 75 percent at eight years  (<a class="graphic graphic_figure graphicRef77529" href="/z/d/graphic/77529.html" rel="external">figure 4</a>) [<a href="#rid12">12,13,33,36,60</a>]. </p><p>Among older patients, endovascular repair is associated with an early survival advantage that gradually decreases over time. Overall five-year survival following AAA repair was 69 percent in one systematic review, with age correlating with worse survival [<a href="#rid61">61</a>]. A propensity-score-matched cohort study involving 39,966 matched pairs of United States Medicare beneficiaries (&gt;65 years of age) found no significant long-term survival advantage for endovascular repair even though perioperative (30-day) mortality was significantly lower for endovascular compared with open repair (1.6 versus 5.2 percent) [<a href="#rid62">62</a>]. The survival advantage for EVAR lasted only through the first three years of follow-up. </p><p>Although small case series have documented acceptable outcomes for EVAR in carefully selected octogenarians and nonagenarians [<a href="#rid63">63-67</a>], continued observation may be warranted for AAA that exceeds 5.5 cm in older patients, particularly among those who are frail for whom a long-term benefit is unlikely [<a href="#rid68">68</a>]. Those with medical comorbidities often die from associated illnesses. (See <a class="local">'Counseling the high-risk patient'</a> below.) </p><p class="headingAnchor" id="H3585421"><span class="h3">Rapid expansion</span><span class="headingEndMark"> — </span>Earlier repair may benefit patients with well-documented rapid aneurysm expansion (&gt;5 mm in six months or 10 mm per year) on serial imaging studies performed by the same modality [<a href="#rid12">12</a>]. Some data suggest that rapidly expanding AAAs are more likely to have symptoms and have a higher risk of rupture. Rapid expansion may represent instability of the aortic wall and may be a sign of impending aortic rupture. (See  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Risk factors'</a>.)</p><p class="headingAnchor" id="H1326316052"><span class="h3">Aneurysm morphology</span><span class="headingEndMark"> — </span>Saccular AAA may be more likely to become symptomatic compared with a fusiform AAA of the same size, but there is no clear evidence that saccular AAA represents a special hazard mandating repair regardless of size [<a href="#rid7">7</a>]. When saccular aneurysm is identified, care should also be taken to rule out infectious etiology or other special circumstances that may require special attention [<a href="#rid69">69</a>]. (See  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm", section on 'Symptomatic (non-ruptured) AAA'</a>.) </p><p class="headingAnchor" id="H3585428"><span class="h3">Coexistent aneurysm or peripheral artery disease</span><span class="headingEndMark"> — </span>Repair of AAA with a diameter that has not exceeded the threshold of 5.5 cm may be reasonable in patients with other associated arterial diseases such as aneurysmal disease of the iliac, femoral, or popliteal arteries, or symptomatic coexistent aortoiliac occlusive arterial disease. It is important to note that aneurysm expansion tends to be less rapid in patients with peripheral artery disease or diabetes mellitus [<a href="#rid13">13,70</a>]. (See  <a class="medical medical_review" href="/z/d/html/15187.html" rel="external">"Popliteal artery aneurysm"</a> and  <a class="medical medical_review" href="/z/d/html/15703.html" rel="external">"Iliac artery aneurysm"</a>.)</p><p>Repair of suprarenal and/or thoracoabdominal aneurysms involves more extensive surgery and greater operative risk. For this reason, and considering that the normal diameter of the proximal aorta is larger, repair of such aneurysms is typically not undertaken until the aortic diameter has exceeded 5.5 to 6.0 cm. (See  <a class="medical medical_review" href="/z/d/html/8189.html" rel="external">"Management of thoracic aortic aneurysm in adults"</a>.)</p><p class="headingAnchor" id="H3585830"><span class="h1">MEDICAL RISK ASSESSMENT</span><span class="headingEndMark"> — </span>The primary goal of elective AAA repair is to prevent rupture and minimize aneurysm-related morbidity and mortality. The assessment of risk for elective aneurysm repair versus the risks of observation should include the patient's expected survival from other medical conditions. Repair may not be warranted if the expected mortality rate from another condition is higher than the expected aneurysm-related mortality. Updated guidelines from the Society for Vascular Surgery (SVS) for the care of patients with AAA suggest the use of the Vascular Quality Initiative perioperative mortality risk score to aid decision making for elective AAA [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/15189.html" rel="external">"Open surgical repair of abdominal aortic aneurysm", section on 'Estimation of perioperative risk'</a>.)</p><p>Patients with coexistent coronary artery disease and cigarette smokers with chronic obstructive pulmonary disease are more likely to experience serious perioperative complications (eg, myocardial ischemia, arrhythmias, pneumonia) [<a href="#rid71">71,72</a>]. </p><p class="bulletIndent1"><span class="glyph">●</span>Patients diagnosed with AAA have an increased risk for cardiovascular disease, and all patients with AAA should undergo cardiovascular risk assessment [<a href="#rid28">28,73-75</a>]. This increase in risk was illustrated in a prospective study that identified AAA in 8.8 percent of patients screened; AAA was &lt;3.5 cm in diameter in 88 percent of the patients [<a href="#rid73">73</a>]. During a 4.5-year follow-up period, patients with AAA had a higher overall mortality than those without AAA (adjusted risk [RR] 1.3, 95% CI 1.04-1.67) and an increased risk of incidental cardiovascular disease (adjusted risk 1.57, 95% CI 1.18-2.07). In a systematic review that included 21 studies of patients with small AAA (&lt;5.5 cm) also reporting cardiovascular outcomes (although there was wide variability in definitions used), the prevalence of ischemic heart disease among those with small AAA was 45 percent, 27 percent for myocardial infarction, and 14 percent for stroke [<a href="#rid28">28</a>]. (See  <a class="medical medical_review" href="/z/d/html/6616.html" rel="external">"Evaluation of cardiac risk prior to noncardiac surgery"</a> and  <a class="medical medical_review" href="/z/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The prevalence of smoking in randomized trials among patients undergoing AAA repair is 24 to 40 percent [<a href="#rid12">12,76-79</a>]. Current smokers and patients with a significant smoking history or pulmonary disease should be evaluated based upon standard guidelines for assessing perioperative risk. Patients with severe pulmonary disease who are not candidates for general anesthesia may be considered for endovascular aneurysm repair if there are no other contraindications for endovascular repair. Smoking cessation prior to elective surgery is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/6917.html" rel="external">"Evaluation of perioperative pulmonary risk"</a> and  <a class="medical medical_review" href="/z/d/html/6970.html" rel="external">"Strategies to reduce postoperative pulmonary complications in adults", section on 'Smoking cessation'</a>.)</p><p></p><p>The risk for perioperative morbidity and mortality related to elective AAA repair is also increased in those with renal dysfunction, female patients, and older patients.</p><p>Renal failure is overall uncommon after AAA repair. One study identified six risk factors associated with renal failure (defined as a requirement of postoperative renal replacement therapy) following open AAA repair [<a href="#rid80">80</a>]. These included preoperative creatinine &gt;1.7 mg/dL, age &gt;75 years, symptomatic AAA, AAA rupture, treated hypertension, and pulmonary disease. Preoperative renal dysfunction was the strongest predictor of postoperative renal failure. In a study that evaluated data from the UK EVAR trials, there did not appear to be any significant long-term difference in renal function comparing endovascular with open AAA repair [<a href="#rid81">81</a>].</p><p class="headingAnchor" id="H3592986"><span class="h1">CONSERVATIVE MANAGEMENT</span><span class="headingEndMark"> — </span>Based upon the result of randomized trials, patients with AAA &lt;5.5 cm in diameter should be managed conservatively. The natural history of AAA is generally one of progressive expansion [<a href="#rid82">82</a>]. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.)</p><p class="headingAnchor" id="H4263691450"><span class="h2">Follow-up and surveillance</span><span class="headingEndMark"> — </span>Patients with small and medium-sized AAA and high-risk patients who are being managed conservatively should undergo periodic clinical evaluation to evaluate for any symptoms that might be related to the aneurysm, and to monitor blood pressure and the success of risk reduction strategies. (See <a class="local">'Cardiovascular risk reduction'</a> below.)</p><p>Only a small proportion of patients diagnosed with AAA as part of a screening program meet the criteria for AAA repair at the time of the initial diagnosis or later during surveillance. Based on information from screening studies, patients with AAA &lt;5.5 cm can be reassured that the risk of rupture is very small, although not zero, underscoring the need for period clinical evaluation and surveillance of aneurysm diameter [<a href="#rid40">40</a>]. Indeed, patients with small aneurysms who do not undergo scheduled surveillance or who are lost to follow-up may be up to six times more likely to present with rupture [<a href="#rid83">83</a>]. Among patients identified with small AAA (≥3.6 cm), in one study, follow-up was overall poor at 65 percent [<a href="#rid84">84</a>]. The rate of follow-up is even poorer for those identified incidentally on imaging studies performed for another reason [<a href="#rid85">85</a>]. During a period of follow-up, about 10 percent of patients under surveillance whose AAA was identified as a result of a screening examination may be expected to require surgery related to aneurysmal expansion (nonruptured) during their lifetime. It is important to note that only a small fraction of all clinically recognized AAA, small or large, are identified as the result of screening programs. Overall, for all methods of AAA diagnosis (ie, screening, physical examination, incidental imaging), the likelihood of needing surgical repair due to initial aneurysm diameter or enlargement during a period of surveillance is approximately 70 percent. </p><p>For patients who elect no repair or who are not candidates for any type of repair, ongoing evaluation and surveillance is <strong>not</strong> needed. (See <a class="local">'Counseling the high-risk patient'</a> below.)</p><p class="headingAnchor" id="H1258861470"><span class="h3">Imaging</span></p><p class="headingAnchor" id="H2647380023"><span class="h4">Aneurysm imaging</span><span class="headingEndMark"> — </span>Patients with asymptomatic AAA under observation for possible future repair should undergo periodic imaging to assess for aortic expansion, but evidence to support an optimal surveillance schedule is not clear [<a href="#rid12">12,13,17,36,86-88</a>]. We generally obtain annual ultrasound for aneurysms &lt;5.5 cm; however, a more frequent interval (eg, every six months) may be used depending upon the characteristics of the aneurysm (eg, larger diameter ≥4.5, greater expansion rate) or patient-related factors (eg, patient anxiety). </p><p>Our preference for annual ultrasound for AAA &lt;4.5 cm (or more frequently for larger aneurysm, or other factors) is based on the low cost of ultrasound and the following reasons: </p><p class="bulletIndent1"><span class="glyph">●</span>Annual clinical examination and risk reduction assessment can be performed concurrently with ultrasound surveillance [<a href="#rid89">89,90</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>When the aneurysm surveillance interval is extended beyond one year, the inherent inaccuracies associated with aortic measurements using ultrasound and computed tomography (CT) become more relevant. Multiple studies obtained over more frequent intervals help resolve conflicts and are more likely to capture rapid aortic expansion. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>There is a potential for patients to be lost to follow-up when extended surveillance intervals are used. Gaps in surveillance of AAA are associated with AAA rupture [<a href="#rid83">83,84</a>]. Thus, when a longer surveillance interval is chosen, it is important to have a reminder system in place. In a database review of nearly 10,000 patients with known AAA who underwent repair of an intact or ruptured aneurysm, gaps in surveillance were defined as no imaging within one year prior to surgery or no imaging for more than two years after the initial image [<a href="#rid83">83</a>]. Patients with ruptured AAA were significantly more likely to have gaps in surveillance compared with those receiving repair for intact AAA (47.4 versus 11.8 percent). In a multivariate analysis, gaps in surveillance remained the largest predictor of rupture after adjusting for medical comorbidities (odds ratio [OR] 5.82, 95% CI 4.64-7.31).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Anxiety is often associated with a diagnosis of AAA, and many patients find reassurance with demonstration of aneurysm diameter stability, as well as a fixed surveillance interval [<a href="#rid91">91</a>]. Admittedly, for many patients, these anxieties may be reduced with proper education.</p><p></p><p>While annual surveillance (or more frequent) is our preference, updated guidelines from the Society for Vascular Surgery (SVS) support longer surveillance intervals for small AAAs and suggest the following surveillance schedule [<a href="#rid7">7,17</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>For initial ultrasound screening aortic diameter &gt;2.5 cm but &lt; 3.0 cm, rescreening after 10 years </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For AAA 3.0 to 3.9 cm, imaging at 3-year intervals</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For AAA 4.0 to 4.9 cm, imaging at 12-month intervals</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>For AAA 5.0 to 5.4 cm, imaging at 6-month intervals</p><p></p><p>This recommendation was based on studies evaluating aneurysm progression. In the United Kingdom small aneurysm study, surveillance intervals were used to minimize the likelihood of aneurysm expansion to greater than 5.5 cm between screening visits [<a href="#rid70">70</a>]. As might be expected, the recommended intervals for surveillance were shorter for larger aneurysms and longer for smaller aneurysms. Surveillance was every 3 months for AAA 5.0 to 5.4 cm, every 12 months for AAA 4.5 to 4.9 cm, every 24 months for AAA 4.0 to 4.4 cm, and every 36 months for AAA 3.5 to 3.8 cm. In this study, less frequent surveillance was felt to be safe, and the suggested surveillance schedule resulted in a &lt;1 percent chance of an aneurysm surpassing 5.5 cm in diameter between screening visits [<a href="#rid92">92</a>]. These intervals are consistent with those used in the Multicentre Aneurysm Screening Study (MASS) [<a href="#rid93">93</a>]. Based largely upon these studies, multidisciplinary guidelines for the diagnosis and management of peripheral artery disease recommend surveillance every 6 to 12 months using ultrasound or CT for aneurysms 4.0 to 5.4 cm in diameter but a less frequent interval (every two to three years) for aneurysms 3.0 to 4.0 cm in diameter, and every five years for aortic diameter between 2.6 to 2.9 cm [<a href="#rid4">4,7,9,87</a>]. Recommendations for AAA surveillance schedule vary widely around the globe [<a href="#rid87">87</a>]. </p><p>While most surveillance is based upon aneurysm diameter, there is interest in using AAA sac volume for surveillance [<a href="#rid94">94-96</a>]. AAA sac volume has been noted in research studies to change when AAA diameter has not; however, the significance of this observation is unknown. More frequent CT scanning, which is required for this measurement, is expensive and would subject the patient to additional radiation exposure. Thus, we do not use such measurements for routine AAA surveillance.</p><p class="headingAnchor" id="H3843869232"><span class="h4">Other techniques</span><span class="headingEndMark"> — </span>Inflammation helps to mediate AAA, and radiographic modalities that can identify inflammation in the aortic wall are being investigated to predict AAA development, growth, and/or rupture [<a href="#rid97">97-102</a>]. Further study is needed to more accurately quantify associations between inflammation within AAA on imaging and subsequent expansion or rupture before these become clinically useful. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Inflammation and the Th2 response'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span>Ultrasmall superparamagnetic particles of iron oxide (USPIO)-enhanced magnetic resonance (MR) imaging is one modality that has been investigated for the purpose of tracking aortic mural inflammation but with indeterminant results [<a href="#rid98">98,103</a>]. USPIOs are not sufficiently specific to select out pro- versus anti-inflammatory macrophages. Thus, specific molecular targeting agents for activated (M1) macrophages will likely be necessary to improve the positive/negative predictive value of inflammation imaging for tracking AAA progression/outcomes. In a multicenter cohort study that monitored 342 individuals with AAA ≥4 cm for over two years, USPIO enhancement was identified in 42.7 percent of participants, absent in 55.8 percent, and indeterminant in 1.5 percent [<a href="#rid98">98</a>]. Compared with those without uptake, patients with USPIO enhancement had higher rates for the primary outcome of aneurysm rupture or repair (47.3 versus 35.6 percent). Patients with USPIO enhancement also had increased rates of aneurysm expansion compared with those without uptake (3.1 versus 2.5 mm/year), although this was not independent of current smoking habit. Baseline AAA diameter and current smoking also predicted the primary outcome. However, the addition of USPIO enhancement to the multivariate model did not improve prediction of adverse AAA-related events over clinical features alone. It is also important to note that the additional iron load associated with iron-based contrast agents carries its own risk for long-term cardiovascular disease and cancer risk [<a href="#rid104">104</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The use of 18F-fluorodeoxyglucose positron emission tomography (FDG-PET) is also promising but inconsistent for predicting AAA expansion or rupture [<a href="#rid102">102,103</a>]. A systematic review revealed that FDG-PET showed that standardized uptake values (SUVs) either had a negative association with AAA growth or nonstatistically significant associations with AAA expansion [<a href="#rid102">102</a>]; other studies have shown a positive association [<a href="#rid105">105</a>]. </p><p></p><p class="headingAnchor" id="H3715137274"><span class="h3">Safety of antithrombotic therapy</span></p><p class="headingAnchor" id="H2887205594"><span class="h4">Antiplatelet therapy</span><span class="headingEndMark"> — </span>While there is no good evidence to support the use of antiplatelet agents for preventing clinical progression of AAA, antiplatelet therapy is indicated as a general intervention to reduce the risk of future cardiovascular events in patients with AAA. (See <a class="local">'Uncertain benefit for limiting AAA expansion'</a> below and <a class="local">'Cardiovascular risk reduction'</a> below.)</p><p>It is currently unknown whether ASA alone has a substantial effect with respect to hemorrhage in association with AAA rupture. Theoretically, thrombus formation would be impeded; however, the retroperitoneal structures probably play a greater role in limiting the initial expansion of hematoma following AAA rupture. In general, we feel that the beneficial effects of ASA in reducing cardiovascular morbidity and mortality outweigh the theoretic risks of increased bleeding with AAA rupture. </p><p class="headingAnchor" id="H4269100650"><span class="h4">Anticoagulation</span><span class="headingEndMark"> — </span>Patients with indications for anticoagulation (eg, atrial fibrillation) should be treated as indicated. There is no evidence that chronic anticoagulation alters the natural history of AAA. </p><p>Mural thrombus associated with AAA is a consequence of altered flow, but the exact relationship between luminal thrombus volume and pattern of distribution on AAA expansion is not well defined. Mural thrombus associated with AAA is typically firm clot tightly adherent to the aortic wall; however, it can embolize distally, but there are no data to suggest that chronic anticoagulation modifies the risk [<a href="#rid106">106</a>]. If embolization does occur, the patient is considered "symptomatic" and is a candidate for AAA repair. (See  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm"</a>.)</p><p>Even in the absence of embolism, the appearance of thrombus that is not adherent to the lateral margins of the aneurysm sac (eg, floating), or changes in mural thrombus (eg, fractured, displaced), may indicate a rapid change has occurred in AAA diameter, or may even herald rupture. (See  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Ruptured versus nonruptured AAA'</a>.)</p><p class="headingAnchor" id="H4062103840"><span class="h4">Thrombolytic therapy</span><span class="headingEndMark"> — </span>Thrombolytics are commonly used for a variety of indications (eg, acute stroke, pulmonary embolism, acute limb ischemia). There is evidence from case reviews that thrombolytics can destabilize AAA mural thrombus, leading to dislodgement and distal embolism, and possibly to aortic leak [<a href="#rid107">107,108</a>]. When reviewing potential administration of thrombolytic therapies, the overall benefits of treating the underlying condition must be weighed against the possible harms. While bleeding risks predominate, the potential complications related to the aneurysm should be considered, and if it is elected to proceed with thrombolysis, then the patient should also be monitored for possible aneurysm-related complications.</p><p class="headingAnchor" id="H1916657650"><span class="h3">Fluoroquinolone use</span><span class="headingEndMark"> — </span>Based on data from observational studies that the use of fluoroquinolones may increase the occurrence of aortic aneurysm or dissection [<a href="#rid109">109-113</a>], the US Food and Drug Administration (FDA) issued an updated safety communication in December 2018 stating that fluoroquinolones may increase the occurrence of aortic aneurysm or dissection [<a href="#rid114">114</a>]. Some have suggested that any effect may be more related to inflammatory changes occurring with the infection being treated, rather than a particular antibiotic [<a href="#rid115">115</a>]. Studies published after the FDA communication are reviewed separately. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Fluoroquinolones and other antimicrobials used to treat infection'</a>.)</p><p>The FDA recommends the following: </p><p class="bulletIndent1"><span class="glyph">●</span>Avoid prescribing fluoroquinolone antibiotics to patients who have an aortic aneurysm. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Only prescribe fluoroquinolones to these patients when no other treatment option is available.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Advise all patients to seek immediate medical treatment for any symptoms associated with aortic aneurysm or dissection. (See  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Symptomatic (nonruptured) AAA'</a> and  <a class="medical medical_review" href="/z/d/html/15229.html" rel="external">"Clinical features and diagnosis of abdominal aortic aneurysm", section on 'Ruptured AAA'</a> and  <a class="medical medical_review" href="/z/d/html/8178.html" rel="external">"Overview of acute aortic dissection and other acute aortic syndromes"</a> and  <a class="medical medical_review" href="/z/d/html/8190.html" rel="external">"Clinical features and diagnosis of acute aortic dissection"</a>.)</p><p></p><p class="headingAnchor" id="H2319832942"><span class="h3">Counseling the high-risk patient</span><span class="headingEndMark"> — </span>Asymptomatic patients with AAA repair &gt;5.5 cm who have medical comorbidities that increase their risk for repair (open surgical or endovascular) above the expected level may be best managed conservatively, reserving repair only if symptoms develop (including rupture). (See  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm"</a>.)</p><p>In a database review by the Vascular Study Group of New England, among 1653 patients undergoing endovascular aneurysm repair, 19 percent were deemed unfit to undergo open aneurysm repair [<a href="#rid116">116</a>]. Patients who were unfit for open repair were older and more likely to have cardiac disease or chronic obstructive pulmonary disease. By contrast, compared with those deemed fit for open AAA repair, patients deemed unfit had significantly higher rates of cardiac (7.8 versus 3.1 percent) and pulmonary (3.6 versus 1.6 percent) complications. Survival for those deemed unfit was significantly worse than those deemed fit (one-year survival 93 versus 96 percent; three-year survival 73 versus 89 percent, and five-year survival 61 versus 80 percent). Even adjusting for age, designation as unfit was a significant predictor of worse five-year survival (hazard ratio 1.6, 95% CI 1.2-2.2). In a review of outcomes in males with screen-detected large AAA deemed not fit for repair, death occurred in 14/34 at a median of 34.9 months after diagnosis, 9 from ruptured AAA [<a href="#rid117">117</a>]. Long-term outcomes for patients deemed unfit for open surgery should also be considered when considering endovascular repair. (See <a class="local">'Open versus endovascular aneurysm repair'</a> below.) </p><p>Expected rupture rates for untreated patients vary depending on the population studied, aneurysm diameter, and other risk factors for rupture (eg, smoking, chronic obstructive pulmonary disease, unmanaged medical conditions). The biology of AAA may also be changing. The risk of rupture and death has been declining, in parallel with reductions in per capita smoking [<a href="#rid118">118</a>]. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>One study evaluated 198 males with contraindications to repair or refusal [<a href="#rid119">119</a>]. The one-year incidence of rupture (and death) was 9.4 percent for AAA 5.5 to 5.9 cm in diameter, 10.2 percent for AAA 6.0 to 6.9 cm, and 37.5 percent for AAA &gt;7.0 cm. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In another study of 72 patients who were deemed unfit for AAA repair, median survival for AAA 5.1 to 6.0 cm was 44 months and 11 percent died of rupture; for AAA 6.1 and 7.0 cm, median survival was 26 months and 20 percent died of rupture; and for AAA &gt;7 cm, survival was six months and 43 percent ruptured [<a href="#rid120">120</a>]. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>In a later study that included 1514 patients with untreated AAA, cumulative annual rupture rates were 3.5 percent for AAAs 5.5 to 6.0 cm, 4.1 percent for AAAs 6.1 to 7.0 cm, and 6.3 percent for AAAs &gt;7.0 cm [<a href="#rid121">121</a>]. </p><p></p><p>Long-term survival in high-risk patients may be unaffected by repair. The EVAR 2 (Endovascular repair of aortic aneurysm in patients physically ineligible for open repair) trial randomly assigned 404 patients with AAA &gt;5.5 cm and who were aged 60 years or older to endovascular aneurysm repair or no intervention [<a href="#rid16">16</a>]. The endovascular group had a lower risk of aneurysm-related mortality (adjusted hazard ratio [HR] 0.53, 95% CI 0.32-0.89), but there were no significant differences in all-cause mortality (HR 0.99, 95% CI 0.78-1.27) at eight-year follow-up. </p><p>Decision making in high-risk patients is difficult but should include a candid discussion with the patient and family or other caretakers. This discussion should include counseling the patient to create an advanced directive detailing the patient's wishes in the event of rupture. Family members or other caretakers should be made aware of these wishes, given that the patient may not be able to report their wishes at the time of aneurysm rupture. </p><p class="headingAnchor" id="H185925151"><span class="h2">Cardiovascular risk reduction</span><span class="headingEndMark"> — </span>Multidisciplinary guidelines regard AAA as a coronary heart disease equivalent and recommend risk reduction strategies, which include medical therapy (antiplatelet therapy, statin therapy, antihypertensive therapy), smoking cessation and aerobic exercise to reduce the risk of future cardiovascular events, unless contraindicated [<a href="#rid4">4</a>]. However, these therapies do not appear to significantly reduce rates of AAA expansion [<a href="#rid122">122</a>]. There is also <strong>no</strong> evidence to suggest that <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> therapy contributes in any way to initiating AAA expansion or rupture. (See <a class="local">'Therapies to limit aortic expansion'</a> below and  <a class="medical medical_review" href="/z/d/html/1505.html" rel="external">"Prevention of cardiovascular disease events in those with established disease (secondary prevention) or at very high risk"</a>.)</p><p>In a study that included over 12,000 patients with a diagnosis of AAA, the percentage use of medications to manage cardiovascular risk increased from 2000 to 2012 (from 26 to 77 percent for statins, 56 to 74 percent for antiplatelet agents, and 75 to 84 percent for antihypertensive drugs) [<a href="#rid123">123</a>]. On Kaplan-Meier analysis, five-year survival improved for patients receiving compared with not receiving each therapy (68 versus 42 percent for statins, 64 versus 40 percent for antiplatelet agents, and 62 versus 39 percent for antihypertensive agents). </p><p>Managing cardiovascular risk is also important for improving overall outcomes associated with AAA repair (open surgical or endovascular repair) given that approximately one half of patients with small AAA who are being conservatively managed will eventually undergo AAA repair [<a href="#rid4">4,9,124,125</a>]. In a systematic review of 14 cohort studies, statin treatment among nearly 70,000 AAA patients was associated with a 35 percent relative reduction in total mortality (rate ratio 0.65, 95% CI 0.57-0.73) with a median follow-up of 3.1 years [<a href="#rid126">126</a>]. Perioperative (30 day) mortality was not significantly different. Other studies have similarly found a benefit for statin therapy for patients with AAA [<a href="#rid122">122,126-139</a>]. </p><p>Patients with hypertension should be evaluated and treated to recommended blood pressure goals. No specific antihypertensive therapy has, thus far, been shown to alter the natural history of AAA. Whenever possible, patients should avoid blood pressure spikes. (See  <a class="medical medical_review" href="/z/d/html/3852.html" rel="external">"Overview of hypertension in adults"</a> and  <a class="medical medical_review" href="/z/d/html/3861.html" rel="external">"Goal blood pressure in adults with hypertension"</a> and <a class="local">'Uncertain benefit for limiting AAA expansion'</a> below and <a class="local">'Aerobic exercise'</a> below.)</p><p class="headingAnchor" id="H91188805"><span class="h2">Therapies to limit aortic expansion</span><span class="headingEndMark"> — </span>The likelihood that an aneurysm will expand or rupture is influenced by a number of factors, including aneurysm diameter, rate of expansion, sex, ongoing smoking, recent surgery, and other medical factors [<a href="#rid86">86,140</a>]. These risk factors are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Expansion and rupture of AAA'</a>.)</p><p>Medical management of AAA is focused on modifiable risk factors for AAA and cardiovascular disease with the goals of reducing the need for intervention due to aneurysm expansion or rupture, reducing morbidity and mortality associated with repair, and reducing cardiovascular morbidity and mortality [<a href="#rid141">141,142</a>]. Among the factors associated with AAA expansion and rupture, smoking is the most important modifiable risk factor, and we recommend smoking cessation for all patients with AAA (see <a class="local">'Smoking cessation'</a> below). Although reduced aneurysm expansion and rupture risk have not been clearly demonstrated among those who have stopped smoking, smoking cessation has other benefits. In addition, because AAA is regarded as a coronary risk equivalent, we agree with major society guidelines that recommend <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a> (ASA) and statin therapy for patients with AAA to reduce the risk of a future cardiovascular event, unless contraindicated [<a href="#rid4">4,7,9</a>]. Many pharmacologic therapies aimed at limiting AAA expansion and preventing rupture have been investigated, but none has proven successful at achieving these goals, and as such, we suggest <strong>not</strong> implementing any of the pharmacologic therapies discussed below <strong>for the</strong> <strong>sole purpose</strong> <strong>of treating AAA</strong>. Individual medical conditions should be treated as appropriate (eg, hypertension).</p><p class="headingAnchor" id="H91192084"><span class="h3">Potentially beneficial therapies</span></p><p class="headingAnchor" id="H3584839"><span class="h4">Smoking cessation</span><span class="headingEndMark"> — </span>Cigarette smoking is the risk factor most strongly associated with aneurysm formation, aneurysm expansion, and aneurysm rupture and is the most important modifiable risk factor in patients with AAA [<a href="#rid70">70,140,142-145</a>]. We agree with multidisciplinary guidelines that individuals diagnosed with AAA and those who have a family history of AAA be advised to stop smoking and offered cessation interventions [<a href="#rid4">4,7,9,146</a>]. Smoking cessation has many other benefits. The management of smoking cessation is discussed in detail elsewhere. (See  <a class="medical medical_review" href="/z/d/html/16706.html" rel="external">"Benefits and consequences of smoking cessation"</a> and  <a class="medical medical_review" href="/z/d/html/16634.html" rel="external">"Overview of smoking cessation management in adults"</a>.)</p><p>Smoking cessation is presumed to provide a benefit by reducing the harmful effects of smoking in mediating connective tissue degradation, although this has not been proven [<a href="#rid147">147</a>]. With smoking cessation, the risk of developing AAA slowly declines over time [<a href="#rid140">140,144</a>], but the effect of smoking cessation on AAA that is already formed is unknown. There are no controlled trials of smoking cessation in patients with AAA, and it is unlikely that any such studies will ever be performed. However, former smokers undergoing AAA repair have lower rates of aneurysm-related mortality and all-cause mortality compared with current smokers, suggesting the importance of smoking cessation [<a href="#rid148">148,149</a>]. Smoking cessation for at least two months prior to AAA repair was found in one prospective study to significantly reduce the incidence of postoperative respiratory complications (57 versus 15 percent) [<a href="#rid150">150</a>]. </p><p class="headingAnchor" id="H3584846"><span class="h4">Aerobic exercise</span><span class="headingEndMark"> — </span>It is widely accepted that higher levels of physical activity are associated with a lower risk of cardiovascular morbidity and death. We agree that patients with AAA should participate in an exercise program for secondary prevention of cardiovascular disease. Patients should be counseled that moderate physical activity such as running, biking, swimming, hiking, or sexual activity and activities such as gardening, golfing, and horseback riding do <strong>not</strong> precipitate AAA rupture [<a href="#rid151">151</a>]. However, heavy lifting, especially while holding the breath, and other activities that lead to Valsalva transiently induce significant increases in blood pressure and should be avoided. </p><p>Moderate physical therapy may also limit aneurysm expansion [<a href="#rid152">152,153</a>]. In experimental aneurysms, increased aortic blood flow appears to inhibit AAA expansion [<a href="#rid154">154</a>]. Magnetic resonance imaging in patients with AAA who have exercised has demonstrated increased abdominal aortic blood flow [<a href="#rid155">155</a>], and thus, exercise may have the potential to limit AAA expansion in humans as well. Although the exact mechanisms remain to be determined, exercise reduces the levels of systemic markers of inflammation relevant to AAAs. One trial that randomly assigned 140 patients with AAA &lt;5.5 cm found no significant effect of an exercise program on AAA expansion rates over an average of 23 months [<a href="#rid156">156,157</a>]. There were marked improvements in exercise capacity in the training group, and there was a modest inverse association between the change in exercise capacity and change in AAA diameter. (See  <a class="medical medical_review" href="/z/d/html/1510.html" rel="external">"Exercise and fitness in the prevention of atherosclerotic cardiovascular disease"</a> and  <a class="medical medical_review" href="/z/d/html/2786.html" rel="external">"The benefits and risks of aerobic exercise"</a>.)</p><p class="headingAnchor" id="H91192146"><span class="h3">Uncertain benefit for limiting AAA expansion</span><span class="headingEndMark"> — </span>A number of drug targets that may inhibit AAA formation or progression have been identified in animal models and in vitro studies. These studies have generated much interest for the treatment of patients with small aneurysms; however, to date, there is no proven evidence that any of these targets unequivocally prevents aortic expansion and rupture [<a href="#rid158">158-164</a>]. A multicenter study that identified 5362 patients with AAA found no significant association between AAA progression and usage of statins, beta blockers, angiotensin-converting enzyme inhibitors, or angiotensin II receptor blockers [<a href="#rid165">165</a>]. </p><p class="headingAnchor" id="H3593747"><span class="h4">Beta blocker therapy</span><span class="headingEndMark"> — </span>Beta blockers have a role in managing patients with cardiovascular disease, but they have not been clearly shown to reduce aneurysm expansion rates [<a href="#rid166">166</a>]. (See  <a class="medical medical_review" href="/z/d/html/6615.html" rel="external">"Management of cardiac risk for noncardiac surgery", section on 'Beta blockers'</a>.)</p><p>A number of early animal studies and retrospective reviews suggested that beta blockers may inhibit AAA expansion [<a href="#rid166">166-170</a>]. One study evaluated 121 patients with an infrarenal aortic aneurysm who were monitored by serial ultrasound examination; 38 of the patients were treated with a beta blocker [<a href="#rid167">167</a>]. The mean expansion rate was significantly lower in the patients receiving a beta blocker (0.36 versus 0.68 cm per year). However, two large trials found no significant differences in AAA expansion rates in patients receiving beta blockers compared with those who did not [<a href="#rid166">166,171</a>]. The lack of benefit may have been related to poor compliance due to the side effects of beta blockade that measurably diminished quality of life. Although these studies did not show a benefit for <a class="drug drug_general" data-topicid="9829" href="/z/d/drug information/9829.html" rel="external">propranolol</a> in limiting AAA expansion, they do not exclude the possibility that a better-tolerated selective beta-adrenergic blocker could be beneficial. </p><p class="headingAnchor" id="H3593855"><span class="h4">ARBs and ACE inhibitors</span><span class="headingEndMark"> — </span>Although animal studies have suggested the utility of angiotensin receptor blockers or angiotensin-converting enzyme (ACE) inhibitors in decreasing the rate of aneurysm expansion [<a href="#rid172">172,173</a>], the clinical use of these agents has not clearly demonstrated the same benefits [<a href="#rid174">174</a>]. Infusion of angiotensin II into rodents promotes AAA formation, which is thought to be due to aortic inflammation and proteolysis and not due to the secondary increase in blood pressure [<a href="#rid175">175-177</a>]. Angiotensin type 1 receptor blockade (ARB) usually [<a href="#rid178">178-183</a>], but not always [<a href="#rid179">179</a>], inhibits aneurysm development in various animal models such as AAAs induced by angiotensin II, AAAs induced by chemical agents, and AAAs in mice genetically predisposed to aneurysm. ACE inhibitors are not reliable for inhibiting experimental AAA development [<a href="#rid178">178,179,184</a>]. </p><p>A number of clinical studies have associated reduced rates of AAA expansion or rupture with the use of ACE inhibitors and ARBs [<a href="#rid174">174,185-187</a>]. A study of 15,326 patients who presented with AAA (intact or ruptured) evaluated the prehospital use of ACE inhibitors [<a href="#rid185">185</a>]. Patients taking ACE inhibitors were significantly less likely to present with ruptured aneurysm compared with those who were not on ACE inhibitors (OR 0.82, 95% CI 0.74-0.90). By contrast, a report from the United Kingdom Small AAA study found an increased risk of AAA expansion for patients on ACE inhibitors [<a href="#rid187">187</a>]. A later multicenter trial randomly assigned 224 patients ≥55 years of age with AAA diameter 3.0 to 5.4 cm to <a class="drug drug_general" data-topicid="9758" href="/z/d/drug information/9758.html" rel="external">perindopril</a> arginine 10 mg, <a class="drug drug_general" data-topicid="8627" href="/z/d/drug information/8627.html" rel="external">amlodipine</a> 5 mg, or placebo [<a href="#rid188">188</a>]. Annual expansion rates (1.68, 1.77, and 1.81 mm, respectively) were similar between the groups, and similar numbers of patients in each group underwent elective surgery for AAA &gt;5.5 cm diameter. In the <a class="drug drug_general" data-topicid="10275" href="/z/d/drug information/10275.html" rel="external">Telmisartan</a> in the Management of Abdominal Aortic Aneurysm (TEDY) trial, changes in CT-measured AAA diameters and the rate of AAA related events were also similar for telmisartan compared with placebo [<a href="#rid189">189</a>].</p><p class="headingAnchor" id="H3593877"><span class="h4">Other antihypertensive agents</span><span class="headingEndMark"> — </span>Diuretics and calcium channel blockers have also been studied for their effects on AAA expansion. Although a trend toward lower expansion rates has been observed for calcium channel blockers, significant differences have not been seen [<a href="#rid70">70</a>]. Diuretics appear to have no impact on expansion rates. </p><p class="headingAnchor" id="H3593884"><span class="h4">Statin therapy</span><span class="headingEndMark"> — </span>The pathogenesis of AAA involves diminished integrity of the arterial wall driven by local inflammation, an altered balance in arterial wall repair, and degradation by enzymes such as matrix metalloproteinases (MMPs) [<a href="#rid190">190</a>]. Statins reduce the expression of MMPs in a concentration-dependent manner, independent of their cholesterol-lowering effects [<a href="#rid191">191,192</a>]. </p><p>Animal studies suggest that statins may limit AAA expansion [<a href="#rid193">193-198</a>]. However, the influence of statins for inhibiting atherosclerosis may be relatively greater [<a href="#rid197">197</a>]. No randomized trials have specifically assessed the effect of statins on AAA expansion or rupture. A number of observational studies have examined the effect of statin therapy on the expansion of small AAAs [<a href="#rid128">128,139,186,187,199-204</a>]. Early studies reported reduced rates of AAA expansion in patients treated with statins [<a href="#rid128">128,139,200,202-204</a>]; however, most larger studies have not confirmed a relationship [<a href="#rid186">186,187,201,205,206</a>]. In the Trømso study, statin therapy was associated with an increased risk of developing AAA (OR 3.8, 95% CI 1.45-9.81) [<a href="#rid143">143</a>]. However, in a population-based case control study that included 7168 patients, a decreased risk for AAA rupture was found for current statin users compared with never users (OR 0.70, 95% CI 0.61-0.95), a risk difference that persisted after adjustment for confounding factors [<a href="#rid199">199</a>]. However, multiple meta-analyses found no evidence that statins impact AAA expansion rate but did observe a survival benefit for those on statins [<a href="#rid122">122,207</a>]. Thus, although there is insufficient evidence to recommend the initiation of statin therapy solely for the treatment of AAAs [<a href="#rid141">141</a>], statin therapy should be considered for patients with AAA to reduce overall cardiovascular risk.</p><p class="headingAnchor" id="H3203499725"><span class="h4">Metformin</span><span class="headingEndMark"> — </span>Diabetes is associated with reduced expansion rates. (See  <a class="medical medical_review" href="/z/d/html/15190.html" rel="external">"Epidemiology, risk factors, pathogenesis, and natural history of abdominal aortic aneurysm", section on 'Negative risk factors'</a>.)</p><p>Some have speculated that diabetes medication effects may play a role, either indirectly (ie, as a measure of increasing diabetes severity) and/or directly. Observational studies suggest reduced rates of AAA expansion in patients with diabetes who have a subscription for <a class="drug drug_general" data-topicid="9621" href="/z/d/drug information/9621.html" rel="external">metformin</a> [<a href="#rid208">208-211</a>]. Prospective randomized trials testing the efficacy of metformin in limiting AAA progression in patients without diabetes are either planned or underway in several different countries around the world. </p><p class="headingAnchor" id="H3594098"><span class="h4">Antiplatelet therapy</span><span class="headingEndMark"> — </span>Antiplatelet therapy may influence the formation of thrombus within AAA and reduce progression in patients with small AAA, but a definitive association between platelet inhibition and aneurysm progression has not been identified [<a href="#rid186">186</a>].<strong> </strong></p><p>The use of antiplatelet agents (eg, <a class="drug drug_general" data-topicid="8907" href="/z/d/drug information/8907.html" rel="external">aspirin</a>) is postulated to decrease thrombus formation, reduce aortic wall inflammation, and stabilize the aortic wall [<a href="#rid212">212</a>]. The volume of thrombus within AAAs correlates to maximum AAA diameter [<a href="#rid213">213</a>], and circulating concentrations of thrombin degradation products (D-dimer) are strongly associated with the presence of AAA and progression in patients with small AAAs [<a href="#rid214">214,215</a>]. Thrombus from human infrarenal AAAs also contains inflammatory cells [<a href="#rid216">216,217</a>]. In animal models, platelet inhibition has been found to limit AAA formation [<a href="#rid217">217,218</a>]. Although a number of clinical studies have been performed, antiplatelet therapy has not been evaluated in randomized trials [<a href="#rid128">128,139,186,187,200-204,212</a>]. In one study, ASA was associated with decreased rates of progression of small AAA [<a href="#rid212">212</a>]. However, larger studies have found no significant association between antiplatelet therapy and AAA expansion [<a href="#rid186">186,187,201</a>].</p><p class="headingAnchor" id="H3594222"><span class="h4">Anti-inflammatory agents</span><span class="headingEndMark"> — </span>A characteristic histological feature of human AAA is a dense inflammatory infiltrate with a variety of cells, including macrophages, neutrophils, and lymphocytes, typically present [<a href="#rid219">219,220</a>]. </p><p>Elastases (proteases) secreted from these cells degrade the normal arterial wall architecture and, particularly, the elastic lamellae. Aortic thrombus also contains neutrophils and high concentrations of proinflammatory cytokines and proteolytic enzymes [<a href="#rid216">216,217</a>]. Inhibition of these inflammatory cells suppresses the development of AAA in rodent models [<a href="#rid221">221</a>]. A number of protease inhibitors have been developed as antineoplastic agents, but most have side effects that would limit their use in patients with AAA [<a href="#rid222">222</a>]. </p><p>Mast cells, which contain chymase and other proinflammatory cytokines, may contribute to AAA formation [<a href="#rid223">223</a>]. Mice that are deficient in this cell type are protected from experimental AAA [<a href="#rid224">224,225</a>]. These findings have raised interest in the use of mast cell stabilizing agents in patients with small AAAs. However, a trial that randomized 326 patients to pemirolast or placebo found no significant differences in small AAA (3.0 to 4.9 cm) expansion rates (mean 2.42 mm) over a 12-month period [<a href="#rid226">226</a>]. </p><p class="headingAnchor" id="H1586570796"><span class="h3">No benefit</span></p><p class="headingAnchor" id="H3387360676"><span class="h4">Doxycycline</span><span class="headingEndMark"> — </span>Randomized trials show that there is no benefit for <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> in reducing AAA expansion in spite of encouraging preclinical studies and may indicate that some of the available methods used for generating aneurysms in animals may be inadequate for modeling human disease. </p><p>It was initially postulated that aneurysm progression may be enhanced by secondary microbial infection within the aortic wall. Serologic evidence of <em>Chlamydia pneumoniae</em> infection was associated with an increased rate of AAA expansion [<a href="#rid227">227</a>], and two small trials suggested that roxithromycin may decrease AAA expansion rates [<a href="#rid228">228,229</a>]. Although infection is known to potentially lead to the formation of aneurysms, clear evidence supporting a role for infection in the formation and progression of the majority of AAAs (noninfected) has not been established [<a href="#rid151">151,228</a>]. It was recognized that the commonly used <a class="drug drug_general" data-topicid="9986" href="/z/d/drug information/9986.html" rel="external">tetracycline</a> antibiotics suppressed inflammatory markers [<a href="#rid230">230,231</a>], and inhibited matrix metalloproteinases (MMPs) in vitro [<a href="#rid232">232</a>] and in aneurysm tissue [<a href="#rid233">233,234</a>]. MMPs are postulated to play a role in aneurysm formation. In at least 14 separate studies in animal models, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> has been found to inhibit aneurysm development and progression [<a href="#rid161">161,235</a>]. In two animal studies, rapamycin similarly inhibited experimentally induced AAA [<a href="#rid236">236,237</a>]. </p><p>In humans, <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> does not reduce AAA expansion:</p><p class="bulletIndent1"><span class="glyph">●</span>The PHarmaceutical Aneurysm Stabilization Trial (PHAST) did not find a reduction in growth of small AAA (3.5 to 5.0 cm) following 18 months of <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> (100 mg daily) compared with placebo; rather, aneurysm expansion was greater in the doxycycline group (4.1 mm versus 3.3 mm), but this was not considered to be clinically relevant [<a href="#rid238">238</a>]. Doxycycline treatment did not influence the need for or timing of elective AAA repair. The study was limited by the high number of patients lost from the study due to nonadherence, adverse treatment effects, or elective AAA repair.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A second trial with more complete follow-up randomly assigned 261 individuals 50 years or older with small infrarenal AAA (aortic diameter 3.5 to 5.0 cm for men, 3.5 to 4.5 cm for females) to 100 mg oral <a class="drug drug_general" data-topicid="9393" href="/z/d/drug information/9393.html" rel="external">doxycycline</a> or placebo twice daily [<a href="#rid158">158,239</a>]. Doxycycline did not reduce aneurysm expansion; the change in AAA maximum transverse diameter measured from CT images at baseline and follow-up at two years was similar (0.36 cm for each group). Mortality and the need for AAA repair were also similar. Loss to follow-up was low (3 percent) in this trial.</p><p></p><p class="headingAnchor" id="H1191821755"><span class="h1">AAA REPAIR</span><span class="headingEndMark"> — </span>Elective abdominal aortic aneurysm (AAA) repair is the most effective management to prevent rupture. Two methods of aneurysm repair are currently available: open surgery and endovascular aneurysm repair (EVAR). The mortality of elective AAA repair is 3 to 5 percent for open AAA repair but lower at 0.5 to 2 percent for EVAR [<a href="#rid240">240-242</a>]. When choosing the type of repair, it is important to take into account the patient's expected survival (short-term and long-term), which depends upon the patient's age and medical comorbidities. (See <a class="local">'Medical risk assessment'</a> above.)</p><p class="bulletIndent1"><span class="glyph">●</span>Open AAA repair – Open aneurysm repair involves replacement of the diseased aortic segment with a tube or bifurcated prosthetic graft  (<a class="graphic graphic_figure graphicRef56289" href="/z/d/graphic/56289.html" rel="external">figure 5</a>) through a midline abdominal or retroperitoneal incision [<a href="#rid243">243</a>]. With technical refinements for open AAA repair, complications such as acute renal failure, distal embolization, wound infection, colonic ischemia, false aneurysm formation, aorto-duodenal fistula, graft infection, and perioperative bleeding have become less common following routine elective surgery but remain significant issues following emergent open AAA repair. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>EVAR – EVAR involves the placement of modular graft components delivered via the iliac or femoral arteries to line the aorta  (<a class="graphic graphic_figure graphicRef56289" href="/z/d/graphic/56289.html" rel="external">figure 5</a>) and exclude the aneurysm sac from the circulation. EVAR requires fulfillment of specific anatomic criteria. Up to 70 percent of patients are EVAR candidates. This percentage is expected to increase with the approval of specialized endograft designs that will allow the treatment of more challenging aortic aneurysm anatomy. Although EVAR is associated with lower perioperative mortality, late AAA rupture has been reported. </p><p></p><p class="headingAnchor" id="H786575"><span class="h2">Summary of indications for elective AAA repair</span><span class="headingEndMark"> — </span>Repair of asymptomatic AAA is generally indicated under the circumstances listed below. These indications are discussed in more detail above. Repair of symptomatic (nonruptured) and ruptured AAA are discussed separately. (See <a class="local">'Aneurysm repair versus conservative management'</a> above and  <a class="medical medical_review" href="/z/d/html/15191.html" rel="external">"Management of symptomatic (non-ruptured) and ruptured abdominal aortic aneurysm"</a>.) </p><p class="bulletIndent1"><span class="glyph">●</span>Asymptomatic AAA ≥5.5 cm in males; asymptomatic AAA &gt; 5.0 in females</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Rapidly expanding AAA </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>AAA associated with peripheral arterial aneurysm (eg, iliac, popliteal) or symptomatic peripheral artery disease (eg, iliac occlusive disease) undergoing revascularization </p><p></p><p class="headingAnchor" id="H1635442670"><span class="h2">Outpatient versus inpatient preoperative evaluation</span><span class="headingEndMark"> — </span>Most patients with asymptomatic AAA can be managed on an outpatient basis. For those with indications for AAA repair, the patient and their family or other caretakers should be counseled regarding the risk of rupture prior to definitive repair and informed of potential symptoms that can be associated with AAA and encouraged to communicate the development of any symptoms to their surgeon and primary care physician. (See  <a class="medical medical_review" href="/z/d/html/15189.html" rel="external">"Open surgical repair of abdominal aortic aneurysm", section on 'Preoperative evaluation'</a> and  <a class="medical medical_review" href="/z/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm", section on 'Anatomic suitability'</a>.)</p><p>On occasion, a patient will present clinically with a very large (≥6.0 cm in diameter) asymptomatic AAA that may warrant admission and inpatient evaluation. Although there are no data to assist with clinical management of very large, asymptomatic AAA or any uniformly accepted standards of care, we suggest immediate referral to a vascular surgeon because of the high risk for rupture. We suggest earlier rather than later aneurysm repair once appropriate preoperative studies, medical risk assessment, and assessment of aortoiliac anatomy are completed. There is no advantage to an excessive delay. For patients found to have a very large, asymptomatic AAA in a practice setting that does not have vascular expertise, we suggest referral to a vascular center in a timely manner. </p><p>Very large, asymptomatic AAA has an estimated rupture risk over a 12-month period of 10 to 20 percent for those between 6 and 7 cm, 20 to 40 percent for those 7 to 8 cm, and 30 to 50 percent for those larger than 8 cm. The rupture risk over a period of weeks or months during the intervening period from the time of initial diagnosis and definitive treatment is not known. Rupture can occur during this interval. Because of the potential for rupture, some vascular surgeons routinely admit patients with very large, asymptomatic AAA for preoperative evaluation, but the validity of this practice has not been substantiated. </p><p class="headingAnchor" id="H783678"><span class="h2">Open versus endovascular aneurysm repair</span><span class="headingEndMark"> — </span>Randomized trials comparing open AAA repair with EVAR have found significantly improved short-term (30-day) morbidity and mortality for EVAR but no significant differences in long-term outcomes up to 10 years [<a href="#rid77">77,244-253</a>]. A pooled analysis of these trials identified a 69 percent reduction in the risk for perioperative mortality for endovascular compared with open repair (odds ratio [OR] 0.33, 95% CI 0.17-0.64) [<a href="#rid254">254</a>]. EVAR appears to be associated with the need for more secondary procedures and an ongoing future risk of aortic rupture. However, there appears to be no significant differences in overall complication rates when all complications for each procedure are included [<a href="#rid255">255</a>]. The important points of these randomized trials are summarized below. </p><p class="headingAnchor" id="H3594568"><span class="h3">DREAM trial</span><span class="headingEndMark"> — </span>The Dutch Randomized Endovascular Aneurysm Management (DREAM) trial randomly assigned 351 patients to open repair or EVAR [<a href="#rid76">76</a>]. All patients had AAA &gt;5 cm in maximal diameter and were suitable candidates for either technique. </p><p>The perioperative (30-day) mortality rate was lower for EVAR compared with open AAA repair (1.2 versus 4.6 percent), though this result was not significant. At two-years post-randomization, the cumulative rates of aneurysm-related death remained less for EVAR (2.1 versus 5.7 percent) compared with open repair, a difference that was entirely due to the initial perioperative outcomes [<a href="#rid247">247</a>]. However, there were no significant differences in overall survival (89.7 percent for EVAR and 89.6 percent for open repair). The perioperative survival advantage seen with EVAR was not sustained after the first postoperative year, due to an increase in non-aneurysm-related mortality in the EVAR group. These results were maintained at six years with survival rates for EVAR at 68.9 percent and open repair at 69.9 percent [<a href="#rid248">248</a>].<sup> </sup></p><p>The rate of moderate and severe systemic complications was significantly lower for EVAR (11.7 versus 26.4 percent) compared with open repair. Rates of moderate and severe vascular or graft-related complications were significantly greater for EVAR (16.4 versus 8.6 percent) compared with open repair. The need for secondary vascular intervention was significantly higher for EVAR (29.6 versus 18.1 percent) compared with open repair.</p><p class="headingAnchor" id="H3594590"><span class="h3">EVAR-1 trial</span><span class="headingEndMark"> — </span>The endovascular aneurysm repair versus open repair in patients with AAA (EVAR1) trial randomly assigned 1252 patients to AAA repair with EVAR (n = 626) or open AAA repair (n = 626) [<a href="#rid249">249</a>]. Perioperative (30-day) mortality was significantly less for EVAR (1.8 versus 4.3 percent). No significant differences were seen in overall mortality, and graft-related complications occurred more frequently with EVAR. New complications related to EVAR continued to occur out to eight years of follow-up [<a href="#rid77">77</a>]. The early benefit of EVAR was lost beginning approximately eight years after randomization due to late fatal secondary aneurysm ruptures. Over a mean of 12.7 years of follow-up, the overall mortality rate was similar (9.3 versus 8.9 deaths per 100 person-years for the EVAR and open groups, respectively) [<a href="#rid256">256</a>]. However, aneurysm-related mortality was significantly increased for EVAR after eight years (7 versus 1 percent) and was mainly attributable to secondary aneurysm sac rupture. Whether newer-generation stent-grafts would have these same long-term aneurysm-related risks is unknown; over one-third of the stent-graft devices received by the enrollees in this study are no longer used [<a href="#rid249">249</a>]. </p><p>Another finding of longer-term follow-up was that the number of cancer deaths was 50 of 179 in the EVAR group and 31 of 154 in the open group (after eight years, adjusted hazard ratio 1.87, 95% CI 1.19-2.96). No other study has observed an increased cancer risk with the use of aortic stent-grafts. In the EVAR group, 37 of 50 of these cancer deaths were described as "other" (ie, not lung cancer). If these were abdominal cancers, their increased detection could be related to more frequent surveillance. Based upon estimated cancer risks [<a href="#rid257">257,258</a>], it is unlikely these can be attributed to imaging-related radiation exposure. Reintervention rates were significantly higher for EVAR compared with open repair. </p><p>A criticism of this trial was that all complications related to open repair, such as incisional hernia, were not included in the study. The short-term benefit of EVAR was lost due to late fatal aneurysm ruptures. The authors concluded that treatment by EVAR significantly reduced the operative mortality compared with open repair, but there were no long-term advantages of one type of repair for aneurysm-related or overall mortality.</p><p class="headingAnchor" id="H3594604"><span class="h3">OVER trial</span><span class="headingEndMark"> — </span>The Open Versus Endovascular Repair (OVER) trial is an ongoing multicenter trial at the Veterans Affairs Medical Centers that randomly assigned 881 veterans ≥49 with AAA &gt;5.0 cm, an associated iliac aneurysm with maximal diameter ≥3.0 cm, or a diameter of ≥4.5 cm with rapid enlargement (defined as 0.5 cm growth in six months or 1.0 cm in one year) to open AAA repair or EVAR [<a href="#rid78">78,251,259</a>]. Patients were candidates for either type of repair. </p><p>EVAR was associated with significantly shorter procedure times (2.9 versus 3.7 hours), a shorter duration of mechanical ventilation (3.6 versus 5.0 hours), shorter intensive care unit stay (1 versus 4 days), shorter length of hospital length (3 versus 7 days), and lower transfusion requirements (0 versus 1 unit). </p><p>Overall mortality was not significantly different between the groups (68 percent EVAR, 70 percent open repair) over 14 years of follow-up [<a href="#rid251">251,259</a>]. There was a postoperative survival advantage for endovascular repair (0.5 versus 2.5 percent; between group difference -2.1 percent, 95% CI -3.7 to -0.5), and overall survival initially appeared higher in the endovascular group up to four years follow-up, but thereafter, no significant differences were seen. There was also no significant difference in aneurysm-related death (overall 28/608; 12 endovascular; 16 open repair). </p><p>Aneurysm rupture (confirmed) occurred in more patients in the endovascular group (7 versus 1; between group difference 1.3 percent, 95% CI 0.1-2.6). The aneurysm rupture in the open repair patient occurred in the thoracic aorta. There were no significant differences for other causes of death. It is important to note that the cause of death was not known or could not be verified for 93 patients (8.6 percent of endovascular; 12.6 percent of open repair).</p><p>In addition, significantly more patients in the endovascular-repair group underwent secondary procedures (27 versus 20 percent; between group difference 6.9 percent, 95% CI 2.0-17.5). In this trial, incisional hernia was included as an open-repair-related secondary procedure. A separate database review found similar complication rates between open and endovascular repair when all complications were included [<a href="#rid255">255</a>]. </p><p class="headingAnchor" id="H3594618"><span class="h3">ACE trial</span><span class="headingEndMark"> — </span>The Aneurysme de l'aorte abdominale: Chirurgie versus Endoprothese (ACE) trial randomly assigned 316 patients with AAA &gt;5 cm to EVAR or open surgery [<a href="#rid250">250</a>]. As with the studies above, there were no significant differences in the cumulative survival or major adverse events rates (95.9 versus 93.2 percent at one-year follow-up, and 85.1 versus 82.4 percent, respectively, at three-year follow-up). In-hospital mortality was also not significantly different (0.6 versus 1.3 percent). The need for reintervention was higher in the EVAR group (16 versus 2.4 percent), compared with open AAA repair, although incisional hernia repair was not considered. </p><p class="headingAnchor" id="H783739"><span class="h2">Choice of AAA repair approach</span><span class="headingEndMark"> — </span>When it has been determined that a patient should undergo elective AAA repair, we agree with guidelines from major medical and surgical societies that emphasize an individualized approach when choosing the type of AAA repair, taking into account the anatomic factors, patient age, sex, risk for AAA rupture, and risk for perioperative morbidity and mortality [<a href="#rid4">4,7,9,260-267</a>]: </p><p class="bulletIndent1"><span class="glyph">●</span>Endovascular repair may be preferred in patients with favorable anatomy (as defined by the "instructions for use" of a given device) who are at a high level of perioperative risk. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Endovascular repair may be appropriate in patients with favorable anatomy but who do not have a high surgical risk. </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Open surgical repair may be preferred for younger patients who have a low or average perioperative risk.</p><p></p><p>Based upon the randomized trials presented above, the main benefits of EVAR appear to be the greatest in the short term, and thus, EVAR is the most appropriate choice for patients with a limited life expectancy and those with a high level of perioperative risk. In a review of studies limited to patients 80 years of age or older, perioperative mortality, overall complications, and specific complications (cardiac, renal, pulmonary, bleeding) were all significantly reduced for endovascular compared with open surgical repair [<a href="#rid268">268</a>]. At three- and five-year follow-up, survival was similar in the two groups. </p><p>However, whether younger patients who are not at high risk for open surgery should undergo open surgical repair versus EVAR remains controversial [<a href="#rid269">269-273</a>]. Surveillance of endovascular stent grafts over an extended period of time exposes the patient to greater levels of cumulative radiation; however, ultrasound surveillance is becoming more common. Although EVAR does not eliminate the risk of future aortic rupture, this is also true for open AAA repair, which can have late complications such as anastomotic pseudoaneurysm (proximal, distal) and development/progression of iliac or suprarenal aneurysms. In a Veterans administration study in the United States that assessed total mean costs related to open versus endovascular repair, there were no significant differences (mean 5.2 years follow-up) [<a href="#rid274">274</a>]. (See  <a class="medical medical_review" href="/z/d/html/15203.html" rel="external">"Endovascular repair of abdominal aortic aneurysm", section on 'Endograft surveillance'</a> and  <a class="medical medical_review" href="/z/d/html/16918.html" rel="external">"Complications of endovascular abdominal aortic repair"</a>.) </p><p>In the United States, about 80 percent of AAAs are repaired using an endovascular approach [<a href="#rid275">275</a>]. For patients with anatomy that is suitable for endovascular repair (ie, as defined by the instructions for use of a given device), the authors speculate that this rate is nearly 100 percent, given that most of the limitations to EVAR have fallen away with newer generation devices, as well as a better understanding of the modes of failure following endovascular repair. However, the management of AAA varies widely worldwide, with percentages of EVAR that can be much lower, largely related to variations in availability of equipment, levels of training, and reimbursement policies [<a href="#rid275">275</a>]. </p><p class="headingAnchor" id="H568395095"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/118036.html" rel="external">"Society guideline links: Aortic and other peripheral aneurysms"</a> and  <a class="medical medical_society_guidelines" href="/z/d/html/118637.html" rel="external">"Society guideline links: Acute extremity ischemia"</a>.)</p><p class="headingAnchor" id="H909597042"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15324.html" rel="external">"Patient education: Abdominal aortic aneurysm (The Basics)"</a>) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/3429.html" rel="external">"Patient education: Abdominal aortic aneurysm (Beyond the Basics)"</a>) </p><p></p><p class="headingAnchor" id="H909597049"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Abdominal aortic aneurysm</strong> – Abdominal aortic aneurysm (AAA) is a common and potentially life-threatening condition. Approximately 7000 deaths per year are attributed to ruptured AAA in the United States. Without repair, ruptured AAA is nearly uniformly fatal. For asymptomatic patients, elective repair of the aneurysm is the most effective management to prevent rupture. (See <a class="local">'Introduction'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymptomatic</strong> <strong>small AAA</strong> – For most patients with asymptomatic infrarenal AAA &lt;5.5 cm, we recommend conservative management (watchful waiting) rather than elective AAA repair (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). The risk of aneurysm rupture does not exceed the risk of repair until the aneurysm diameter reaches 5.5 cm. However, there are situations for which elective repair of asymptomatic AAA &lt;5.5 cm may also be appropriate. These may include rapidly expanding AAA (&gt;0.5 cm in six months or &gt;1 cm per year), coexistent aneurysm/peripheral artery disease, and female sex. (see <a class="local">'Aneurysm repair versus conservative management'</a> above):</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Conservative management</strong> – Conservative management consists of periodic clinical evaluation and imaging surveillance to identify AAA that exceeds the threshold for repair or is rapidly expanding. Medical therapies for patients with AAA focus on the management of modifiable risk factors for AAA and cardiovascular disease with the goals of reducing the need for intervention due to aneurysm expansion or rupture, reducing morbidity and mortality associated with AAA repair, and reducing cardiovascular morbidity and mortality. (See <a class="local">'Conservative management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Smoking cessation</strong> – For patients with AAA who smoke, we recommend smoking cessation (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). Smoking is strongly associated with AAA expansion and rupture and is the most important modifiable risk factor. Even though reduced aneurysm expansion and rupture risk have not been clearly demonstrated among those who have stopped smoking, smoking cessation has other clear benefits. (See  <a class="medical medical_review" href="/z/d/html/16706.html" rel="external">"Benefits and consequences of smoking cessation"</a>.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>No medical therapies proven to limit AAA expansion</strong> – Although many pharmacologic therapies aimed at limiting AAA expansion and preventing rupture have been tried, no therapy has been proven successful at achieving these goals, and as such, we suggest not implementing any of the pharmacologic therapies discussed above for the sole purpose of treating AAA (<a class="grade" href="https:///uptodate/show/grade_6" rel="external">Grade 2C</a>). (See <a class="local">'Therapies to limit aortic expansion'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Asymptomatic large AAA </strong>– For good-risk surgical candidates (open or endovascular repair) with AAA &gt;5.5 cm, we recommend elective AAA repair (<a class="grade" href="https:///uptodate/show/grade_1" rel="external">Grade 1A</a>). For patients with AAA &gt;5.5 cm who have a short life expectancy (&lt;2 years) due to advanced comorbidities, particularly cardiopulmonary disease or malignancy, we suggest no repair over endovascular aneurysm repair (<a class="grade" href="https:///uptodate/show/grade_5" rel="external">Grade 2B</a>). For these patients and others who elect not to undergo repair, ongoing AAA surveillance is <strong>not</strong> needed. The patient should be encouraged to create an advanced directive detailing their wishes for no repair of any kind in the event of rupture. Family members or other caretakers should be made aware of these wishes, given that the patient may not be able to report their wishes at the time of aneurysm rupture. (See <a class="local">'Summary of indications for elective AAA repair'</a> above and <a class="local">'Counseling the high-risk patient'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>AAA repair</strong> – The primary goals of aneurysm repair are to prevent rupture while minimizing morbidity and mortality associated with repair. We agree with guidelines from major medical and surgical societies that emphasize an individualized approach when choosing between an open or endovascular approach to AAA repair, accounting for aortic anatomy, patient age, life expectancy, and risk factors for perioperative morbidity and mortality. For patients with favorable anatomy for endovascular repair (as defined by the instructions for use of a given device) and a high level of perioperative risk, we recommend endovascular repair, rather than open surgical repair (<a class="grade" href="https:///uptodate/show/grade_2" rel="external">Grade 1B</a>). (See <a class="local">'Open versus endovascular aneurysm repair'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Surveillance schedule for unrepaired AAA</strong> – The optimal surveillance schedule for patients who are not undergoing AAA repair is not known for certain. The Society for Vascular Surgery (SVS) recommends surveillance every 6 to 12 months using ultrasound or CT for medium-sized aneurysms (4 to 5.4 cm in diameter) but less frequent intervals for smaller aneurysms. We frequently perform surveillance on small aneurysms annually to minimize imaging variability and alleviate patient anxieties. Annual clinical examination and risk reduction assessment can also be performed concurrently with AAA surveillance. (See <a class="local">'Follow-up and surveillance'</a> above.)</p><p></p><p class="headingAnchor" id="H1010793733"><span class="h1">ACKNOWLEDGMENT</span><span class="headingEndMark"> — </span>The UpToDate editorial staff acknowledges Emile R Mohler, III, MD (deceased), who contributed to an earlier version of this topic review. </p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Bown MJ, Sutton AJ, Bell PR, Sayers RD. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br J Surg 2002; 89:714.</a></li><li><a class="nounderline abstract_t">Hoornweg LL, Storm-Versloot MN, Ubbink DT, et al. Meta analysis on mortality of ruptured abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2008; 35:558.</a></li><li><a class="nounderline abstract_t">Johnston KW, Rutherford RB, Tilson MD, et al. Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery. J Vasc Surg 1991; 13:452.</a></li><li><a class="nounderline abstract_t">Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006; 113:e463.</a></li><li><a class="nounderline abstract_t">Dalman RL. The 2019 update of the European abdominal aortic aneurysm guidelines. J Vasc Surg 2019; 69:633.</a></li><li><a class="nounderline abstract_t">Wanhainen A, Verzini F, Van Herzeele I, et al. Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms. Eur J Vasc Endovasc Surg 2019; 57:8.</a></li><li><a class="nounderline abstract_t">Chaikof EL, Dalman RL, Eskandari MK, et al. The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm. J Vasc Surg 2018; 67:2.</a></li><li><a class="nounderline abstract_t">Wanhainen A. How to define an abdominal aortic aneurysm--influence on epidemiology and clinical practice. Scand J Surg 2008; 97:105.</a></li><li><a class="nounderline abstract_t">Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 2011; 58:2020.</a></li><li><a class="nounderline abstract_t">Jongkind V, Yeung KK, Akkersdijk GJ, et al. Juxtarenal aortic aneurysm repair. J Vasc Surg 2010; 52:760.</a></li><li><a class="nounderline abstract_t">Isselbacher EM, Preventza O, Hamilton Black J 3rd, et al. 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2022; 146:e334.</a></li><li><a class="nounderline abstract_t">Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants. Lancet 1998; 352:1649.</a></li><li><a class="nounderline abstract_t">Lederle FA, Wilson SE, Johnson GR, et al. Immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346:1437.</a></li><li><a class="nounderline abstract_t">Cao P, De Rango P, Verzini F, et al. Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial. Eur J Vasc Endovasc Surg 2011; 41:13.</a></li><li><a class="nounderline abstract_t">Ouriel K, Clair DG, Kent KC, et al. Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg 2010; 51:1081.</a></li><li><a class="nounderline abstract_t">United Kingdom EVAR Trial Investigators, Greenhalgh RM, Brown LC, et al. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med 2010; 362:1872.</a></li><li><a class="nounderline abstract_t">Rokosh RS, Wu WW, Eskandari MK, Chaikof EL. Society for Vascular Surgery implementation of guidelines in abdominal aortic aneurysms: Preoperative surveillance and threshold for repair. J Vasc Surg 2021; 74:1053.</a></li><li><a class="nounderline abstract_t">Szilagyi DE, Smith RF, DeRusso FJ, et al. Contribution of abdominal aortic aneurysmectomy to prolongation of life. Ann Surg 1966; 164:678.</a></li><li><a class="nounderline abstract_t">Foster JH, Bolasny BL, Gobbel WG Jr, Scott HW Jr. Comparative study of elective resection and expectant treatment of abdomianl aortic aneurysm. Surg Gynecol Obstet 1969; 129:1.</a></li><li><a class="nounderline abstract_t">Thompson AR, Cooper JA, Ashton HA, Hafez H. Growth rates of small abdominal aortic aneurysms correlate with clinical events. Br J Surg 2010; 97:37.</a></li><li><a class="nounderline abstract_t">Szilagyi DE, Elliott JP, Smith RF. Clinical fate of the patient with asymptomatic abdominal aortic aneurysm and unfit for surgical treatment. Arch Surg 1972; 104:600.</a></li><li><a class="nounderline abstract_t">Katz DA, Littenberg B, Cronenwett JL. Management of small abdominal aortic aneurysms. Early surgery vs watchful waiting. JAMA 1992; 268:2678.</a></li><li><a class="nounderline abstract_t">Nevitt MP, Ballard DJ, Hallett JW Jr. Prognosis of abdominal aortic aneurysms. A population-based study. N Engl J Med 1989; 321:1009.</a></li><li><a class="nounderline abstract_t">Powell JT, Greenhalgh RM. Clinical practice. Small abdominal aortic aneurysms. N Engl J Med 2003; 348:1895.</a></li><li><a class="nounderline abstract_t">Brewster DC, Cronenwett JL, Hallett JW Jr, et al. Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery. J Vasc Surg 2003; 37:1106.</a></li><li class="breakAll">Mitchell MB, Rutherford RB, Krupski WC. Infrarenal aortic aneurysms. In: Vascular Surgery, 4th ed, Rutherford RB (Ed), W.B. Saunders, Philadelphia 1995. p.1032.</li><li><a class="nounderline abstract_t">Ernst CB. Abdominal aortic aneurysm. N Engl J Med 1993; 328:1167.</a></li><li><a class="nounderline abstract_t">Bath MF, Gokani VJ, Sidloff DA, et al. Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm. Br J Surg 2015; 102:866.</a></li><li class="breakAll">Mitchell, MB, Rutherford, et al. Infrarenal aortic aneurysms. In: Vascular Surgery, Rutherford, RB (Eds), WB Saunders, Philadelphia 1995. p.1032.</li><li><a class="nounderline abstract_t">Ouriel K. The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms. J Vasc Surg 2009; 49:266.</a></li><li><a class="nounderline abstract_t">Cao P, CAESAR Trial Collaborators. Comparison of surveillance vs Aortic Endografting for Small Aneurysm Repair (CAESAR) trial: study design and progress. Eur J Vasc Endovasc Surg 2005; 30:245.</a></li><li><a class="nounderline abstract_t">Ulug P, Powell JT, Martinez MA, et al. Surgery for small asymptomatic abdominal aortic aneurysms. Cochrane Database Syst Rev 2020; 7:CD001835.</a></li><li><a class="nounderline abstract_t">Powell JT, Brown LC, Forbes JF, et al. Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial. Br J Surg 2007; 94:702.</a></li><li><a class="nounderline abstract_t">Filardo G, Lederle FA, Ballard DJ, et al. Effect of age on survival between open repair and surveillance for small abdominal aortic aneurysms. Am J Cardiol 2014; 114:1281.</a></li><li><a class="nounderline abstract_t">Brown LC, Thompson SG, Greenhalgh RM, et al. Fit patients with small abdominal aortic aneurysms (AAAs) do not benefit from early intervention. J Vasc Surg 2008; 48:1375.</a></li><li><a class="nounderline abstract_t">United Kingdom Small Aneurysm Trial Participants, Powell JT, Brady AR, et al. Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms. N Engl J Med 2002; 346:1445.</a></li><li><a class="nounderline abstract_t">Eisenstein EL, Davidson-Ray L, Edwards R, et al. Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms. J Vasc Surg 2013; 58:302.</a></li><li><a class="nounderline abstract_t">Sweeting MJ, Patel R, Powell JT, et al. Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair: Very Long-term Follow-up in the EVAR-2 Randomized Controlled Trial. Ann Surg 2017; 266:713.</a></li><li><a class="nounderline abstract_t">EVAR trial participants. Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial. Lancet 2005; 365:2187.</a></li><li><a class="nounderline abstract_t">Oliver-Williams C, Sweeting MJ, Jacomelli J, et al. Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASP. Circulation 2019; 139:1371.</a></li><li><a class="nounderline abstract_t">Mell MW, Baker LC. Payer status, preoperative surveillance, and rupture of abdominal aortic aneurysms in the US Medicare population. Ann Vasc Surg 2014; 28:1378.</a></li><li><a class="nounderline abstract_t">Ohrlander T, Merlo J, Ohlsson H, et al. Socioeconomic position, comorbidity, and mortality in aortic aneurysms: a 13-year prospective cohort study. Ann Vasc Surg 2012; 26:312.</a></li><li><a class="nounderline abstract_t">Heikkinen M, Salenius JP, Auvinen O. Ruptured abdominal aortic aneurysm in a well-defined geographic area. J Vasc Surg 2002; 36:291.</a></li><li><a class="nounderline abstract_t">Naylor AR, Forbes TL. Trans-Atlantic debate: Whether evidence supports reducing the threshold diameter to 5 cm for elective interventions in women with abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2014; 48:611.</a></li><li><a class="nounderline abstract_t">Wanhainen A, Björck M, Boman K, et al. Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm. J Vasc Surg 2001; 34:229.</a></li><li><a class="nounderline abstract_t">Zommorodi S, Bottai M, Hultgren R. Sex differences in repair rates and outcomes of patients with ruptured abdominal aortic aneurysm. Br J Surg 2019; 106:1480.</a></li><li><a class="nounderline abstract_t">Aber A, Tong TS, Chilcott J, et al. Sex differences in national rates of repair of emergency abdominal aortic aneurysm. Br J Surg 2019; 106:82.</a></li><li><a class="nounderline abstract_t">Sweet MP, Fillinger MF, Morrison TM, Abel D. The influence of gender and aortic aneurysm size on eligibility for endovascular abdominal aortic aneurysm repair. J Vasc Surg 2011; 54:931.</a></li><li><a class="nounderline abstract_t">Desai M, Choke E, Sayers RD, et al. Sex-related trends in mortality after elective abdominal aortic aneurysm surgery between 2002 and 2013 at National Health Service hospitals in England: less benefit for women compared with men. Eur Heart J 2016; 37:3452.</a></li><li><a class="nounderline abstract_t">Noronen K, Laukontaus S, Kantonen I, et al. The natural course of abdominal aortic aneurysms that meet the treatment criteria but not the operative requirements. Eur J Vasc Endovasc Surg 2013; 45:326.</a></li><li><a class="nounderline abstract_t">Grootenboer N, van Sambeek MR, Arends LR, et al. Systematic review and meta-analysis of sex differences in outcome after intervention for abdominal aortic aneurysm. Br J Surg 2010; 97:1169.</a></li><li><a class="nounderline abstract_t">Scott SW, Batchelder AJ, Kirkbride D, et al. Late Survival in Nonoperated Patients with Infrarenal Abdominal Aortic Aneurysm. Eur J Vasc Endovasc Surg 2016; 52:444.</a></li><li><a class="nounderline abstract_t">Filardo G, Lederle FA, Ballard DJ, et al. Immediate open repair vs surveillance in patients with small abdominal aortic aneurysms: survival differences by aneurysm size. Mayo Clin Proc 2013; 88:910.</a></li><li><a class="nounderline abstract_t">Sidloff DA, Saratzis A, Sweeting MJ, et al. Sex differences in mortality after abdominal aortic aneurysm repair in the UK. Br J Surg 2017; 104:1656.</a></li><li><a class="nounderline abstract_t">Ulug P, Sweeting MJ, von Allmen RS, et al. Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysis. Lancet 2017; 389:2482.</a></li><li><a class="nounderline abstract_t">Lo RC, Lu B, Fokkema MT, et al. Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women. J Vasc Surg 2014; 59:1209.</a></li><li><a class="nounderline abstract_t">Dimick JB, Stanley JC, Axelrod DA, et al. Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age. Ann Surg 2002; 235:579.</a></li><li><a class="nounderline abstract_t">Lederle FA. Should abdominal aortic aneurysm be managed differently in women? Scand J Surg 2008; 97:125.</a></li><li><a class="nounderline abstract_t">Mehta M, Byrne WJ, Robinson H, et al. Women derive less benefit from elective endovascular aneurysm repair than men. J Vasc Surg 2012; 55:906.</a></li><li><a class="nounderline abstract_t">Lederle FA, Kane RL, MacDonald R, Wilt TJ. Systematic review: repair of unruptured abdominal aortic aneurysm. Ann Intern Med 2007; 146:735.</a></li><li><a class="nounderline abstract_t">Bahia SS, Holt PJ, Jackson D, et al. Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies. Eur J Vasc Endovasc Surg 2015; 50:320.</a></li><li><a class="nounderline abstract_t">Schermerhorn ML, Buck DB, O'Malley AJ, et al. Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population. N Engl J Med 2015; 373:328.</a></li><li><a class="nounderline abstract_t">Lee GK, Ullery BW, Lee JT. Elective EVAR in nonagenarians is safe in carefully selected patients. Ann Vasc Surg 2014; 28:1402.</a></li><li><a class="nounderline abstract_t">Hertault A, Sobocinski J, Kristmundsson T, et al. Results of F-EVAR in octogenarians. Ann Vasc Surg 2014; 28:1396.</a></li><li><a class="nounderline abstract_t">Tsilimparis N, Perez S, Dayama A, Ricotta JJ 2nd. Age-stratified results from 20,095 aortoiliac aneurysm repairs: should we approach octogenarians and nonagenarians differently? J Am Coll Surg 2012; 215:690.</a></li><li><a class="nounderline abstract_t">Hughes K, Abdulrahman H, Prendergast T, et al. Abdominal aortic aneurysm repair in nonagenarians. Ann Vasc Surg 2015; 29:183.</a></li><li><a class="nounderline abstract_t">de Blic R, Alsac JM, Julia P, et al. Elective treatment of abdominal aortic aneurysm is reasonable in patients &gt;85 years of age. Ann Vasc Surg 2014; 28:209.</a></li><li><a class="nounderline abstract_t">Arya S, Kim SI, Duwayri Y, et al. Frailty increases the risk of 30-day mortality, morbidity, and failure to rescue after elective abdominal aortic aneurysm repair independent of age and comorbidities. J Vasc Surg 2015; 61:324.</a></li><li><a class="nounderline abstract_t">Kristmundsson T, Dias N, Resch T, Sonesson B. Morphology of Small Abdominal Aortic Aneurysms Should be Considered before Continued Ultrasound Surveillance. Ann Vasc Surg 2016; 31:18.</a></li><li><a class="nounderline abstract_t">Brady AR, Thompson SG, Fowkes FG, et al. Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance. Circulation 2004; 110:16.</a></li><li><a class="nounderline abstract_t">Dawson J, Vig S, Choke E, et al. Medical optimisation can reduce morbidity and mortality associated with elective aortic aneurysm repair. Eur J Vasc Endovasc Surg 2007; 33:100.</a></li><li><a class="nounderline abstract_t">Faggiano P, Bonardelli S, De Feo S, et al. Preoperative cardiac evaluation and perioperative cardiac therapy in patients undergoing open surgery for abdominal aortic aneurysms: effects on cardiovascular outcome. Ann Vasc Surg 2012; 26:156.</a></li><li><a class="nounderline abstract_t">Newman AB, Arnold AM, Burke GL, et al. Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: the cardiovascular health study. Ann Intern Med 2001; 134:182.</a></li><li><a class="nounderline abstract_t">Hernesniemi JA, Vänni V, Hakala T. The prevalence of abdominal aortic aneurysm is consistently high among patients with coronary artery disease. J Vasc Surg 2015; 62:232.</a></li><li><a class="nounderline abstract_t">Palazzuoli A, Gallotta M, Guerrieri G, et al. Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population. Vasc Health Risk Manag 2008; 4:877.</a></li><li><a class="nounderline abstract_t">Prinssen M, Verhoeven EL, Buth J, et al. A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms. N Engl J Med 2004; 351:1607.</a></li><li><a class="nounderline abstract_t">United Kingdom EVAR Trial Investigators, Greenhalgh RM, Brown LC, et al. Endovascular versus open repair of abdominal aortic aneurysm. N Engl J Med 2010; 362:1863.</a></li><li><a class="nounderline abstract_t">Lederle FA, Freischlag JA, Kyriakides TC, et al. Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial. JAMA 2009; 302:1535.</a></li><li><a class="nounderline abstract_t">Takagi H, Umemoto T, ALICE (All-Literature Investigation of Cardiovascular Evidence) Group. A Meta-Analysis of the Association of Chronic Obstructive Pulmonary Disease with Abdominal Aortic Aneurysm Presence. Ann Vasc Surg 2016; 34:84.</a></li><li><a class="nounderline abstract_t">Grant SW, Grayson AD, Grant MJ, et al. What are the risk factors for renal failure following open elective abdominal aortic aneurysm repair? Eur J Vasc Endovasc Surg 2012; 43:182.</a></li><li><a class="nounderline abstract_t">Brown LC, Brown EA, Greenhalgh RM, et al. Renal function and abdominal aortic aneurysm (AAA): the impact of different management strategies on long-term renal function in the UK EndoVascular Aneurysm Repair (EVAR) Trials. Ann Surg 2010; 251:966.</a></li><li><a class="nounderline abstract_t">Isselbacher EM. Thoracic and abdominal aortic aneurysms. Circulation 2005; 111:816.</a></li><li><a class="nounderline abstract_t">Mell MW, Baker LC, Dalman RL, Hlatky MA. Gaps in preoperative surveillance and rupture of abdominal aortic aneurysms among Medicare beneficiaries. J Vasc Surg 2014; 59:583.</a></li><li><a class="nounderline abstract_t">Chun KC, Schmidt AS, Bains S, et al. Surveillance outcomes of small abdominal aortic aneurysms identified from a large screening program. J Vasc Surg 2016; 63:55.</a></li><li><a class="nounderline abstract_t">Grega DS, Sherman RG. Responsiveness of neurogenic hearts to octopamine. Comp Biochem Physiol C 1975; 52:5.</a></li><li><a class="nounderline abstract_t">Sweeting MJ, Thompson SG, Brown LC, et al. Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms. Br J Surg 2012; 99:655.</a></li><li><a class="nounderline abstract_t">RESCAN Collaborators, Bown MJ, Sweeting MJ, et al. Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis. JAMA 2013; 309:806.</a></li><li><a class="nounderline abstract_t">Badger SA, Jones C, McClements J, et al. Surveillance strategies according to the rate of growth of small abdominal aortic aneurysms. Vasc Med 2011; 16:415.</a></li><li><a class="nounderline abstract_t">Kauffmann C, Tang A, Dugas A, et al. Clinical validation of a software for quantitative follow-up of abdominal aortic aneurysm maximal diameter and growth by CT angiography. Eur J Radiol 2011; 77:502.</a></li><li><a class="nounderline abstract_t">Sarangarm D, Knepper J, Marek J, et al. Post-endovascular aneurysm repair patient outcomes and follow-up are not adversely impacted by long travel distance to tertiary vascular surgery centers. Ann Vasc Surg 2010; 24:1075.</a></li><li><a class="nounderline abstract_t">Marteau TM. Screening for aortic aneurysm: Detection is not as harmful as it might seem. BMJ 2008; 336:973.</a></li><li><a class="nounderline abstract_t">Lederle FA, Johnson GR, Wilson SE, et al. Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators. J Vasc Surg 1997; 26:595.</a></li><li><a class="nounderline abstract_t">Ashton HA, Buxton MJ, Day NE, et al. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 2002; 360:1531.</a></li><li><a class="nounderline abstract_t">Kitagawa A, Mastracci TM, von Allmen R, Powell JT. The role of diameter versus volume as the best prognostic measurement of abdominal aortic aneurysms. J Vasc Surg 2013; 58:258.</a></li><li><a class="nounderline abstract_t">Renapurkar RD, Setser RM, O'Donnell TP, et al. Aortic volume as an indicator of disease progression in patients with untreated infrarenal abdominal aneurysm. Eur J Radiol 2012; 81:e87.</a></li><li><a class="nounderline abstract_t">Kauffmann C, Tang A, Therasse E, et al. Measurements and detection of abdominal aortic aneurysm growth: Accuracy and reproducibility of a segmentation software. Eur J Radiol 2012; 81:1688.</a></li><li><a class="nounderline abstract_t">Richards JM, Semple SI, MacGillivray TJ, et al. Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study. Circ Cardiovasc Imaging 2011; 4:274.</a></li><li><a class="nounderline abstract_t">MA3RS Study Investigators. Aortic Wall Inflammation Predicts Abdominal Aortic Aneurysm Expansion, Rupture, and Need for Surgical Repair. Circulation 2017; 136:787.</a></li><li><a class="nounderline abstract_t">McBride OM, Berry C, Burns P, et al. MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA(3)RS study. Open Heart 2015; 2:e000190.</a></li><li><a class="nounderline abstract_t">Sadat U, Taviani V, Patterson AJ, et al. Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms--a feasibility study. Eur J Vasc Endovasc Surg 2011; 41:167.</a></li><li><a class="nounderline abstract_t">Toczek J, Meadows JL, Sadeghi MM. Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification. Circ Cardiovasc Imaging 2016; 9:e003023.</a></li><li><a class="nounderline abstract_t">Jalalzadeh H, Indrakusuma R, Planken RN, et al. Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers. Eur J Vasc Endovasc Surg 2016; 52:333.</a></li><li><a class="nounderline abstract_t">McBride OM, Joshi NV, Robson JM, et al. Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms. Eur J Vasc Endovasc Surg 2016; 51:518.</a></li><li><a class="nounderline abstract_t">Shen Y, Huang Z, Liu X, et al. Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles. J Cell Mol Med 2015; 19:2032.</a></li><li><a class="nounderline abstract_t">Truijers M, Kurvers HA, Bredie SJ, et al. In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall. J Endovasc Ther 2008; 15:462.</a></li><li><a class="nounderline abstract_t">Cameron SJ, Russell HM, Owens AP 3rd. Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental? Blood 2018; 132:2619.</a></li><li><a class="nounderline abstract_t">Hale PC, Smith SM, Taylor PR. Aortic aneurysm leak after streptokinase treatment for myocardial infarction. Eur J Vasc Surg 1993; 7:738.</a></li><li><a class="nounderline abstract_t">Mayette M, St-Arnaud C. Aortic stent graft leak and aneurysm rupture after alteplase for stroke. CMAJ 2019; 191:E709.</a></li><li><a class="nounderline abstract_t">Newton ER, Akerman AW, Strassle PD, Kibbe MR. Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm. JAMA Surg 2021; 156:264.</a></li><li><a class="nounderline abstract_t">Singh S, Nautiyal A. Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis. Am J Med 2017; 130:1449.</a></li><li><a class="nounderline abstract_t">Gopalakrishnan C, Bykov K, Fischer MA, et al. Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. JAMA Intern Med 2020; 180:1596.</a></li><li><a class="nounderline abstract_t">Dong YH, Chang CH, Wang JL, et al. Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection. JAMA Intern Med 2020; 180:1587.</a></li><li><a class="nounderline abstract_t">Latif A, Ahsan MJ, Kapoor V, et al. Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis. WMJ 2020; 119:185.</a></li><li class="breakAll">https://www.fda.gov/news-events/fda-brief/fda-brief-fda-warns-fluoroquinolone-antibiotics-can-cause-aortic-aneurysm-certain-patients (Accessed on January 25, 2019).</li><li><a class="nounderline abstract_t">Huh K, Kang M, Jung J. Lack of association between fluoroquinolone and aortic aneurysm or dissection. Eur Heart J 2023; 44:4476.</a></li><li><a class="nounderline abstract_t">De Martino RR, Brooke BS, Robinson W, et al. Designation as "unfit for open repair" is associated with poor outcomes after endovascular aortic aneurysm repair. Circ Cardiovasc Qual Outcomes 2013; 6:575.</a></li><li><a class="nounderline abstract_t">Lim J, Wolff J, Rodd CD, et al. Outcome in Men with a Screen-detected Abdominal Aortic Aneurysm Who are not Fit for Intervention. Eur J Vasc Endovasc Surg 2015; 50:732.</a></li><li><a class="nounderline abstract_t">Lederle FA. The rise and fall of abdominal aortic aneurysm. Circulation 2011; 124:1097.</a></li><li><a class="nounderline abstract_t">Lederle FA, Johnson GR, Wilson SE, et al. Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair. JAMA 2002; 287:2968.</a></li><li><a class="nounderline abstract_t">Western CE, Carlisle J, McCarthy RJ, Currie IC. Palliation of abdominal aortic aneurysms in the endovascular era. Eur J Vasc Endovasc Surg 2013; 45:37.</a></li><li><a class="nounderline abstract_t">Parkinson F, Ferguson S, Lewis P, et al. Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair. J Vasc Surg 2015; 61:1606.</a></li><li><a class="nounderline abstract_t">Twine CP, Williams IM. Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms. Br J Surg 2011; 98:346.</a></li><li><a class="nounderline abstract_t">Bahia SS, Vidal-Diez A, Seshasai SR, et al. Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm. Br J Surg 2016; 103:1626.</a></li><li><a class="nounderline abstract_t">Khashram M, Williman JA, Hider PN, et al. Management of Modifiable Vascular Risk Factors Improves Late Survival following Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis. Ann Vasc Surg 2017; 39:301.</a></li><li><a class="nounderline abstract_t">Lindholt JS, Sørensen J, Søgaard R, Henneberg EW. Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial. Br J Surg 2010; 97:826.</a></li><li><a class="nounderline abstract_t">Risum Ø, Sandven I, Sundhagen JO, Abdelnoor M. Editor's Choice - Effect of Statins on Total Mortality in Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis. Eur J Vasc Endovasc Surg 2021; 61:114.</a></li><li><a class="nounderline abstract_t">de Bruin JL, Baas AF, Heymans MW, et al. Statin therapy is associated with improved survival after endovascular and open aneurysm repair. J Vasc Surg 2014; 59:39.</a></li><li><a class="nounderline abstract_t">Heart Protection Study Collaborative Group. Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions. J Vasc Surg 2007; 45:645.</a></li><li><a class="nounderline abstract_t">Feeney JM, Burns K, Staff I, et al. Prehospital HMG Co-A reductase inhibitor use and reduced mortality in ruptured abdominal aortic aneurysm. J Am Coll Surg 2009; 209:41.</a></li><li><a class="nounderline abstract_t">Le Manach Y, Ibanez Esteves C, Bertrand M, et al. Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery. Anesthesiology 2011; 114:98.</a></li><li><a class="nounderline abstract_t">Kertai MD, Boersma E, Westerhout CM, et al. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am J Med 2004; 116:96.</a></li><li><a class="nounderline abstract_t">McNally MM, Agle SC, Parker FM, et al. Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair. J Vasc Surg 2010; 51:1390.</a></li><li><a class="nounderline abstract_t">Diehm N, Becker G, Katzen B, et al. Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis. Vasa 2008; 37:241.</a></li><li><a class="nounderline abstract_t">Schouten O, Lever TM, Welten GM, et al. Long-term cardiac outcome in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair. Eur J Vasc Endovasc Surg 2008; 36:646.</a></li><li><a class="nounderline abstract_t">Leurs LJ, Visser P, Laheij RJ, et al. Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair. Vascular 2006; 14:1.</a></li><li><a class="nounderline abstract_t">Kurzencwyg D, Filion KB, Pilote L, et al. Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair. Ann Vasc Surg 2006; 20:569.</a></li><li><a class="nounderline abstract_t">Kertai MD, Boersma E, Westerhout CM, et al. A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery. Eur J Vasc Endovasc Surg 2004; 28:343.</a></li><li><a class="nounderline abstract_t">Tazaki J, Morimoto T, Sakata R, et al. Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection. J Vasc Surg 2014; 60:604.</a></li><li><a class="nounderline abstract_t">Sukhija R, Aronow WS, Sandhu R, et al. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol 2006; 97:279.</a></li><li><a class="nounderline abstract_t">Kent KC, Zwolak RM, Egorova NN, et al. Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals. J Vasc Surg 2010; 52:539.</a></li><li><a class="nounderline abstract_t">Baxter BT, Terrin MC, Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation 2008; 117:1883.</a></li><li><a class="nounderline abstract_t">Lederle FA, Johnson GR, Wilson SE, et al. The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators. Arch Intern Med 2000; 160:1425.</a></li><li><a class="nounderline abstract_t">Forsdahl SH, Singh K, Solberg S, Jacobsen BK. Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the Tromsø Study, 1994-2001. Circulation 2009; 119:2202.</a></li><li><a class="nounderline abstract_t">Wilmink TB, Quick CR, Day NE. The association between cigarette smoking and abdominal aortic aneurysms. J Vasc Surg 1999; 30:1099.</a></li><li><a class="nounderline abstract_t">Lederle FA, Nelson DB, Joseph AM. Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review. J Vasc Surg 2003; 38:329.</a></li><li><a class="nounderline abstract_t">2011 WRITING GROUP MEMBERS, 2005 WRITING COMMITTEE MEMBERS, ACCF/AHA TASK FORCE MEMBERS. 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 2011; 124:2020.</a></li><li><a class="nounderline abstract_t">Buckley C, Wyble CW, Borhani M, et al. Accelerated enlargement of experimental abdominal aortic aneurysms in a mouse model of chronic cigarette smoke exposure. J Am Coll Surg 2004; 199:896.</a></li><li><a class="nounderline abstract_t">Brown LC, Powell JT. Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants. Ann Surg 1999; 230:289.</a></li><li><a class="nounderline abstract_t">Smoking, lung function and the prognosis of abdominal aortic aneurysm. The UK Small Aneurysm Trial Participants. Eur J Vasc Endovasc Surg 2000; 19:636.</a></li><li><a class="nounderline abstract_t">Warner MA, Offord KP, Warner ME, et al. Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients. Mayo Clin Proc 1989; 64:609.</a></li><li><a class="nounderline abstract_t">Chaikof EL, Brewster DC, Dalman RL, et al. The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines. J Vasc Surg 2009; 50:S2.</a></li><li><a class="nounderline abstract_t">Dalman RL, Tedesco MM, Myers J, Taylor CA. AAA disease: mechanism, stratification, and treatment. Ann N Y Acad Sci 2006; 1085:92.</a></li><li><a class="nounderline abstract_t">Windsor MT, Bailey TG, Perissiou M, et al. Acute Inflammatory Responses to Exercise in Patients with Abdominal Aortic Aneurysm. Med Sci Sports Exerc 2018; 50:649.</a></li><li><a class="nounderline abstract_t">Nakahashi TK, Hoshina K, Tsao PS, et al. Flow loading induces macrophage antioxidative gene expression in experimental aneurysms. Arterioscler Thromb Vasc Biol 2002; 22:2017.</a></li><li><a class="nounderline abstract_t">Tenforde AS, Cheng CP, Suh GY, et al. Quantifying in vivo hemodynamic response to exercise in patients with intermittent claudication and abdominal aortic aneurysms using cine phase-contrast MRI. J Magn Reson Imaging 2010; 31:425.</a></li><li><a class="nounderline abstract_t">Myers J, McElrath M, Jaffe A, et al. A randomized trial of exercise training in abdominal aortic aneurysm disease. Med Sci Sports Exerc 2014; 46:2.</a></li><li><a class="nounderline abstract_t">Myers JN, White JJ, Narasimhan B, Dalman RL. Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial. J Cardiopulm Rehabil Prev 2010; 30:374.</a></li><li><a class="nounderline abstract_t">Baxter BT, Matsumura J, Curci JA, et al. Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA 2020; 323:2029.</a></li><li><a class="nounderline abstract_t">Golledge J, Norman PE, Murphy MP, Dalman RL. Challenges and opportunities in limiting abdominal aortic aneurysm growth. J Vasc Surg 2017; 65:225.</a></li><li><a class="nounderline abstract_t">Bergqvist D. Pharmacological interventions to attenuate the expansion of abdominal aortic aneurysm (AAA) - a systematic review. Eur J Vasc Endovasc Surg 2011; 41:663.</a></li><li><a class="nounderline abstract_t">Golledge J, Norman PE. Current status of medical management for abdominal aortic aneurysm. Atherosclerosis 2011; 217:57.</a></li><li><a class="nounderline abstract_t">Rughani G, Robertson L, Clarke M. Medical treatment for small abdominal aortic aneurysms. Cochrane Database Syst Rev 2012; :CD009536.</a></li><li><a class="nounderline abstract_t">Assar AN. Medical treatment of small abdominal aortic aneurysm. J Cardiovasc Surg (Torino) 2012; 53:517.</a></li><li><a class="nounderline abstract_t">Kokje VB, Hamming JF, Lindeman JH. Editor's Choice - Pharmaceutical Management of Small Abdominal Aortic Aneurysms: A Systematic Review of the Clinical Evidence. Eur J Vasc Endovasc Surg 2015; 50:702.</a></li><li><a class="nounderline abstract_t">Lederle FA, Noorbaloochi S, Nugent S, et al. Multicentre study of abdominal aortic aneurysm measurement and enlargement. Br J Surg 2015; 102:1480.</a></li><li><a class="nounderline abstract_t">Propanolol Aneurysm Trial Investigators. Propranolol for small abdominal aortic aneurysms: results of a randomized trial. J Vasc Surg 2002; 35:72.</a></li><li><a class="nounderline abstract_t">Gadowski GR, Pilcher DB, Ricci MA. Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade. J Vasc Surg 1994; 19:727.</a></li><li><a class="nounderline abstract_t">Brophy CM, Tilson JE, Tilson MD. Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse. J Surg Res 1989; 46:330.</a></li><li><a class="nounderline abstract_t">Leach SD, Toole AL, Stern H, et al. Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms. Arch Surg 1988; 123:606.</a></li><li><a class="nounderline abstract_t">Wilmink AB, Hubbard CS, Day NE, et al.. Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomized study. Br J Surg 2000; 87:499.</a></li><li><a class="nounderline abstract_t">Lindholt JS, Henneberg EW, Juul S, Fasting H. Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms. Int Angiol 1999; 18:52.</a></li><li><a class="nounderline abstract_t">Yamamoto D, Takai S, Jin D, et al. Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9. J Mol Cell Cardiol 2007; 43:670.</a></li><li><a class="nounderline abstract_t">Rizzoni D, Rodella L, Porteri E, et al. Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats. Clin Exp Hypertens 2003; 25:427.</a></li><li><a class="nounderline abstract_t">Salata K, Syed M, Hussain MA, et al. Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair. J Vasc Surg 2018; 67:629.</a></li><li><a class="nounderline abstract_t">Saraff K, Babamusta F, Cassis LA, Daugherty A. Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2003; 23:1621.</a></li><li><a class="nounderline abstract_t">Daugherty A, Manning MW, Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 2000; 105:1605.</a></li><li><a class="nounderline abstract_t">Cassis LA, Gupte M, Thayer S, et al. ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice. Am J Physiol Heart Circ Physiol 2009; 296:H1660.</a></li><li><a class="nounderline abstract_t">Inoue N, Muramatsu M, Jin D, et al. Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice. J Atheroscler Thromb 2009; 16:164.</a></li><li><a class="nounderline abstract_t">Liao S, Miralles M, Kelley BJ, et al. Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors. J Vasc Surg 2001; 33:1057.</a></li><li><a class="nounderline abstract_t">Yang HH, Kim JM, Chum E, et al. Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome. J Thorac Cardiovasc Surg 2010; 140:305.</a></li><li><a class="nounderline abstract_t">Kaschina E, Schrader F, Sommerfeld M, et al. Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation. J Hypertens 2008; 26:2361.</a></li><li><a class="nounderline abstract_t">Fujiwara Y, Shiraya S, Miyake T, et al. Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan. Int J Mol Med 2008; 22:703.</a></li><li><a class="nounderline abstract_t">Habashi JP, Judge DP, Holm TM, et al. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 2006; 312:117.</a></li><li><a class="nounderline abstract_t">da Cunha V, Tham DM, Martin-McNulty B, et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 2005; 178:9.</a></li><li><a class="nounderline abstract_t">Hackam DG, Thiruchelvam D, Redelmeier DA. Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study. Lancet 2006; 368:659.</a></li><li><a class="nounderline abstract_t">Thompson A, Cooper JA, Fabricius M, et al. An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance. J Vasc Surg 2010; 52:55.</a></li><li><a class="nounderline abstract_t">Sweeting MJ, Thompson SG, Brown LC, et al. Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms. J Vasc Surg 2010; 52:1.</a></li><li><a class="nounderline abstract_t">Bicknell CD, Kiru G, Falaschetti E, et al. An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK). Eur Heart J 2016; 37:3213.</a></li><li><a class="nounderline abstract_t">Golledge J, Pinchbeck J, Tomee SM, et al. Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial. JAMA Cardiol 2020; 5:1374.</a></li><li><a class="nounderline abstract_t">Wassef M, Baxter BT, Chisholm RL, et al. Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute. J Vasc Surg 2001; 34:730.</a></li><li><a class="nounderline abstract_t">Nagashima H, Aoka Y, Sakomura Y, et al. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg 2002; 36:158.</a></li><li><a class="nounderline abstract_t">Evans J, Powell JT, Schwalbe E, et al. Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue. Eur J Vasc Endovasc Surg 2007; 34:302.</a></li><li><a class="nounderline abstract_t">Kalyanasundaram A, Elmore JR, Manazer JR, et al. Simvastatin suppresses experimental aortic aneurysm expansion. J Vasc Surg 2006; 43:117.</a></li><li><a class="nounderline abstract_t">Jones A, Deb R, Torsney E, et al. Rosiglitazone reduces the development and rupture of experimental aortic aneurysms. Circulation 2009; 119:3125.</a></li><li><a class="nounderline abstract_t">Zhang Y, Naggar JC, Welzig CM, et al. Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK. Arterioscler Thromb Vasc Biol 2009; 29:1764.</a></li><li><a class="nounderline abstract_t">Steinmetz EF, Buckley C, Shames ML, et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 2005; 241:92.</a></li><li><a class="nounderline abstract_t">Golledge J, Cullen B, Moran C, Rush C. Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm. Cardiovasc Drugs Ther 2010; 24:373.</a></li><li><a class="nounderline abstract_t">Shiraya S, Miyake T, Aoki M, et al. Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration. Atherosclerosis 2009; 202:34.</a></li><li><a class="nounderline abstract_t">Wemmelund H, Høgh A, Hundborg HH, et al. Statin use and rupture of abdominal aortic aneurysm. Br J Surg 2014; 101:966.</a></li><li><a class="nounderline abstract_t">Schouten O, van Laanen JH, Boersma E, et al. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg 2006; 32:21.</a></li><li><a class="nounderline abstract_t">Ferguson CD, Clancy P, Bourke B, et al. Association of statin prescription with small abdominal aortic aneurysm progression. Am Heart J 2010; 159:307.</a></li><li><a class="nounderline abstract_t">Karlsson L, Bergqvist D, Lindbäck J, Pärsson H. Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma. Eur J Vasc Endovasc Surg 2009; 37:420.</a></li><li><a class="nounderline abstract_t">Mosorin M, Niemelä E, Heikkinen J, et al. The use of statins and fate of small abdominal aortic aneurysms. Interact Cardiovasc Thorac Surg 2008; 7:578.</a></li><li><a class="nounderline abstract_t">Schlösser FJ, Tangelder MJ, Verhagen HJ, et al. Growth predictors and prognosis of small abdominal aortic aneurysms. J Vasc Surg 2008; 47:1127.</a></li><li><a class="nounderline abstract_t">Dawson JA, Choke E, Loftus IM, et al. A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2011; 41:28.</a></li><li><a class="nounderline abstract_t">Rahman MN, Khan JA, Mazari FA, et al. A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm. Ann Vasc Surg 2011; 25:32.</a></li><li><a class="nounderline abstract_t">Takagi H, Matsui M, Umemoto T. A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion. J Vasc Surg 2010; 52:1675.</a></li><li><a class="nounderline abstract_t">Fujimura N, Xiong J, Kettler EB, et al. Metformin treatment status and abdominal aortic aneurysm disease progression. J Vasc Surg 2016; 64:46.</a></li><li><a class="nounderline abstract_t">Itoga NK, Rothenberg KA, Suarez P, et al. Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population. J Vasc Surg 2019; 69:710.</a></li><li><a class="nounderline abstract_t">Yu X, Jiang D, Wang J, et al. Metformin prescription and aortic aneurysm: systematic review and meta-analysis. Heart 2019; 105:1351.</a></li><li><a class="nounderline abstract_t">Golledge J, Moxon J, Pinchbeck J, et al. Association between metformin prescription and growth rates of abdominal aortic aneurysms. Br J Surg 2017; 104:1486.</a></li><li><a class="nounderline abstract_t">Lindholt JS, Sorensen HT, Michel JB, et al. Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms. Vasc Endovascular Surg 2008; 42:329.</a></li><li><a class="nounderline abstract_t">Golledge J, Wolanski P, Parr A, Buttner P. Measurement and determinants of infrarenal aortic thrombus volume. Eur Radiol 2008; 18:1987.</a></li><li><a class="nounderline abstract_t">Golledge J, Muller R, Clancy P, et al. Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm. Eur Heart J 2011; 32:354.</a></li><li><a class="nounderline abstract_t">Golledge J, Tsao PS, Dalman RL, Norman PE. Circulating markers of abdominal aortic aneurysm presence and progression. Circulation 2008; 118:2382.</a></li><li><a class="nounderline abstract_t">Houard X, Touat Z, Ollivier V, et al. Mediators of neutrophil recruitment in human abdominal aortic aneurysms. Cardiovasc Res 2009; 82:532.</a></li><li><a class="nounderline abstract_t">Touat Z, Ollivier V, Dai J, et al. Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution. Am J Pathol 2006; 168:1022.</a></li><li><a class="nounderline abstract_t">Dai J, Louedec L, Philippe M, et al. Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model. J Vasc Surg 2009; 49:719.</a></li><li><a class="nounderline abstract_t">Koch AE, Haines GK, Rizzo RJ, et al. Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response. Am J Pathol 1990; 137:1199.</a></li><li><a class="nounderline abstract_t">Newman KM, Jean-Claude J, Li H, et al. Cytokines that activate proteolysis are increased in abdominal aortic aneurysms. Circulation 1994; 90:II224.</a></li><li><a class="nounderline abstract_t">Pagano MB, Zhou HF, Ennis TL, et al. Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm. Circulation 2009; 119:1805.</a></li><li><a class="nounderline abstract_t">Lindeman JH, Rabelink TJ, van Bockel JH. Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde? Circulation 2011; 124:e463.</a></li><li><a class="nounderline abstract_t">Sun J, Zhang J, Lindholt JS, et al. Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation. Circulation 2009; 120:973.</a></li><li><a class="nounderline abstract_t">Sun J, Sukhova GK, Yang M, et al. Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice. J Clin Invest 2007; 117:3359.</a></li><li><a class="nounderline abstract_t">Mäyränpää MI, Trosien JA, Fontaine V, et al. Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms. J Vasc Surg 2009; 50:388.</a></li><li><a class="nounderline abstract_t">Sillesen H, Eldrup N, Hultgren R, et al. Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm. Br J Surg 2015; 102:894.</a></li><li><a class="nounderline abstract_t">Lindholt JS, Ashton HA, Scott RA. Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms. J Vasc Surg 2001; 34:212.</a></li><li><a class="nounderline abstract_t">Vammen S, Lindholt JS, Ostergaard L, et al. Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion. Br J Surg 2001; 88:1066.</a></li><li><a class="nounderline abstract_t">Høgh A, Vammen S, Ostergaard L, et al. Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial. Vasc Endovascular Surg 2009; 43:452.</a></li><li><a class="nounderline abstract_t">Lindeman JH, Abdul-Hussien H, van Bockel JH, et al. Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells. Circulation 2009; 119:2209.</a></li><li><a class="nounderline abstract_t">Walsh DB. Presidential address: Time to lead! J Vasc Surg 2009; 49:519.</a></li><li><a class="nounderline abstract_t">Liu J, Xiong W, Baca-Regen L, et al. Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells. J Vasc Surg 2003; 38:1376.</a></li><li><a class="nounderline abstract_t">Curci JA, Mao D, Bohner DG, et al. Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms. J Vasc Surg 2000; 31:325.</a></li><li><a class="nounderline abstract_t">Baxter BT, Pearce WH, Waltke EA, et al. Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study. J Vasc Surg 2002; 36:1.</a></li><li><a class="nounderline abstract_t">Petrinec D, Liao S, Holmes DR, et al. Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase. J Vasc Surg 1996; 23:336.</a></li><li><a class="nounderline abstract_t">Lawrence DM, Singh RS, Franklin DP, et al. Rapamycin suppresses experimental aortic aneurysm growth. J Vasc Surg 2004; 40:334.</a></li><li><a class="nounderline abstract_t">Rouer M, Xu BH, Xuan HJ, et al. Rapamycin limits the growth of established experimental abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 2014; 47:493.</a></li><li><a class="nounderline abstract_t">Meijer CA, Stijnen T, Wasser MN, et al. Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial. Ann Intern Med 2013; 159:815.</a></li><li><a class="nounderline abstract_t">Baxter BT, Matsumura J, Curci J, et al. Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm. Contemp Clin Trials 2016; 48:91.</a></li><li><a class="nounderline abstract_t">Brady AR, Fowkes FG, Greenhalgh RM, et al. Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants. Br J Surg 2000; 87:742.</a></li><li><a class="nounderline abstract_t">Dillavou ED, Muluk SC, Makaroun MS. Improving aneurysm-related outcomes: nationwide benefits of endovascular repair. J Vasc Surg 2006; 43:446.</a></li><li><a class="nounderline abstract_t">Lee WA, Carter JW, Upchurch G, et al. Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001. J Vasc Surg 2004; 39:491.</a></li><li><a class="nounderline abstract_t">Sieunarine K, Lawrence-Brown MM, Goodman MA. Comparison of transperitoneal and retroperitoneal approaches for infrarenal aortic surgery: early and late results. Cardiovasc Surg 1997; 5:71.</a></li><li><a class="nounderline abstract_t">Bulder RMA, Bastiaannet E, Hamming JF, Lindeman JHN. Meta-analysis of long-term survival after elective endovascular or open repair of abdominal aortic aneurysm. Br J Surg 2019; 106:523.</a></li><li><a class="nounderline abstract_t">Powell JT, Sweeting MJ, Ulug P, et al. Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years. Br J Surg 2017; 104:166.</a></li><li><a class="nounderline abstract_t">Brown LC, Thompson SG, Greenhalgh RM, et al. Incidence of cardiovascular events and death after open or endovascular repair of abdominal aortic aneurysm in the randomized EVAR trial 1. Br J Surg 2011; 98:935.</a></li><li><a class="nounderline abstract_t">Blankensteijn JD, de Jong SE, Prinssen M, et al. Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms. N Engl J Med 2005; 352:2398.</a></li><li><a class="nounderline abstract_t">De Bruin JL, Baas AF, Buth J, et al. Long-term outcome of open or endovascular repair of abdominal aortic aneurysm. N Engl J Med 2010; 362:1881.</a></li><li><a class="nounderline abstract_t">EVAR trial participants. Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial. Lancet 2005; 365:2179.</a></li><li><a class="nounderline abstract_t">Becquemin JP, Pillet JC, Lescalie F, et al. A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients. J Vasc Surg 2011; 53:1167.</a></li><li><a class="nounderline abstract_t">Lederle FA, Freischlag JA, Kyriakides TC, et al. Long-term comparison of endovascular and open repair of abdominal aortic aneurysm. N Engl J Med 2012; 367:1988.</a></li><li><a class="nounderline abstract_t">Paravastu SC, Jayarajasingam R, Cottam R, et al. Endovascular repair of abdominal aortic aneurysm. Cochrane Database Syst Rev 2014; :CD004178.</a></li><li><a class="nounderline abstract_t">Stather PW, Sidloff D, Dattani N, et al. Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm. Br J Surg 2013; 100:863.</a></li><li><a class="nounderline abstract_t">Karthikesalingam A, Thompson MM. Vascular disease: Repair of infrarenal aortic aneurysm--the debate is OVER. Nat Rev Cardiol 2013; 10:122.</a></li><li><a class="nounderline abstract_t">Schermerhorn ML, O'Malley AJ, Jhaveri A, et al. Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population. N Engl J Med 2008; 358:464.</a></li><li><a class="nounderline abstract_t">Patel R, Sweeting MJ, Powell JT, et al. Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial. Lancet 2016; 388:2366.</a></li><li class="breakAll">http://www.xrayrisk.com/calculator/calculator.php (Accessed on November 04, 2016).</li><li><a class="nounderline abstract_t">Berrington de González A, Mahesh M, Kim KP, et al. Projected cancer risks from computed tomographic scans performed in the United States in 2007. Arch Intern Med 2009; 169:2071.</a></li><li><a class="nounderline abstract_t">Lederle FA, Kyriakides TC, Stroupe KT, et al. Open versus Endovascular Repair of Abdominal Aortic Aneurysm. N Engl J Med 2019; 380:2126.</a></li><li><a class="nounderline abstract_t">Coughlin PA, Jackson D, White AD, et al. Meta-analysis of prospective trials determining the short- and mid-term effect of elective open and endovascular repair of abdominal aortic aneurysms on quality of life. Br J Surg 2013; 100:448.</a></li><li><a class="nounderline abstract_t">Biancari F, Catania A, D'Andrea V. Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: systematic review and meta-analysis. Eur J Vasc Endovasc Surg 2011; 42:571.</a></li><li><a class="nounderline abstract_t">Kontopodis N, Antoniou SA, Georgakarakos E, Ioannou CV. Endovascular vs Open Aneurysm Repair in the Young: Systematic Review and Meta-analysis. J Endovasc Ther 2015; 22:897.</a></li><li><a class="nounderline abstract_t">Saedon M, Mt-Isa S, Saratzis A, et al. Outcome of open versus endovascular abdominal aortic aneurysm repair in obese patients: a systemic review and meta-analysis. Int Angiol 2015; 34:9.</a></li><li class="breakAll">http://content.onlinejacc.org/cgi/reprint/47/6/e1.pdf (Accessed on March 23, 2010).</li><li><a class="nounderline abstract_t">Coscas R, Maumias T, Capdevila C, et al. Mini-invasive treatment of abdominal aortic aneurysms: current roles of endovascular, laparoscopic, and open techniques. Ann Vasc Surg 2014; 28:123.</a></li><li><a class="nounderline abstract_t">De Martino RR, Goodney PP, Nolan BW, et al. Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy. J Vasc Surg 2013; 58:589.</a></li><li><a class="nounderline abstract_t">Kumar R, Dattani N, Asaad O, et al. Meta-analysis of Outcomes Following Aneurysm Repair in Patients with Synchronous Intra-abdominal Malignancy. Eur J Vasc Endovasc Surg 2016; 52:747.</a></li><li><a class="nounderline abstract_t">Wang G, Sun Y, Lin Z, Fei X. Elective Endovascular vs Open Repair for Elective Abdominal Aortic Aneurysm in Patients ≥80 years of Age: A Systematic Review and Meta-Analysis. Vasc Endovascular Surg 2023; 57:386.</a></li><li><a class="nounderline abstract_t">Siracuse JJ, Gill HL, Graham AR, et al. Comparative safety of endovascular and open surgical repair of abdominal aortic aneurysms in low-risk male patients. J Vasc Surg 2014; 60:1154.</a></li><li><a class="nounderline abstract_t">Vallabhaneni R, Farber MA, Schneider F, Ricco JB. Debate: whether young, good-risk patients should be treated with endovascular abdominal aortic aneurysm repair. J Vasc Surg 2013; 58:1709.</a></li><li><a class="nounderline abstract_t">Sandford RM, Choke E, Bown MJ, Sayers RD. What is the best option for elective repair of an abdominal aortic aneurysm in a young fit patient? Eur J Vasc Endovasc Surg 2014; 47:13.</a></li><li><a class="nounderline abstract_t">Lee K, Tang E, Dubois L, et al. Durability and survival are similar after elective endovascular and open repair of abdominal aortic aneurysms in younger patients. J Vasc Surg 2015; 61:636.</a></li><li><a class="nounderline abstract_t">Siracuse JJ, Schermerhorn ML, Meltzer AJ, et al. Comparison of outcomes after endovascular and open repair of abdominal aortic aneurysms in low-risk patients. Br J Surg 2016; 103:989.</a></li><li><a class="nounderline abstract_t">Lederle FA, Stroupe KT, Kyriakides TC, et al. Long-term Cost-effectiveness in the Veterans Affairs Open vs Endovascular Repair Study of Aortic Abdominal Aneurysm: A Randomized Clinical Trial. JAMA Surg 2016; 151:1139.</a></li><li><a class="nounderline abstract_t">Beck AW, Sedrakyan A, Mao J, et al. Variations in Abdominal Aortic Aneurysm Care: A Report From the International Consortium of Vascular Registries. Circulation 2016; 134:1948.</a></li></ol></div><div id="topicVersionRevision">Topic 15188 Version 50.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12027981" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18226567" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : Meta analysis on mortality of ruptured abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1999868" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Suggested standards for reporting on arterial aneurysms. Subcommittee on Reporting Standards for Arterial Aneurysms, Ad Hoc Committee on Reporting Standards, Society for Vascular Surgery and North American Chapter, International Society for Cardiovascular Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16549646" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30798841" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The 2019 update of the European abdominal aortic aneurysm guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30528142" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Editor's Choice - European Society for Vascular Surgery (ESVS) 2019 Clinical Practice Guidelines on the Management of Abdominal Aorto-iliac Artery Aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29268916" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18575024" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : How to define an abdominal aortic aneurysm--influence on epidemiology and clinical practice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21963765" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : 2011 ACCF/AHA Focused Update of the Guideline for the Management of Patients With Peripheral Artery Disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20382492" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Juxtarenal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36322642" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9853436" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. The UK Small Aneurysm Trial Participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12000813" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Immediate repair compared with surveillance of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20869890" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Comparison of surveillance versus aortic endografting for small aneurysm repair (CAESAR): results from a randomised trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20304589" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Endovascular repair compared with surveillance for patients with small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20382982" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Endovascular repair of aortic aneurysm in patients physically ineligible for open repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34022377" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Society for Vascular Surgery implementation of guidelines in abdominal aortic aneurysms: Preoperative surveillance and threshold for repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5924789" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Contribution of abdominal aortic aneurysmectomy to prolongation of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5790696" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Comparative study of elective resection and expectant treatment of abdomianl aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20013940" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Growth rates of small abdominal aortic aneurysms correlate with clinical events.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5013802" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Clinical fate of the patient with asymptomatic abdominal aortic aneurysm and unfit for surgical treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1433687" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Management of small abdominal aortic aneurysms. Early surgery vs watchful waiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2674715" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Prognosis of abdominal aortic aneurysms. A population-based study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12736283" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Clinical practice. Small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756363" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12756363" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Guidelines for the treatment of abdominal aortic aneurysms. Report of a subcommittee of the Joint Council of the American Association for Vascular Surgery and Society for Vascular Surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8455684" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25974255" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25974255" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Systematic review of cardiovascular disease and cardiovascular death in patients with a small abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19174266" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : The PIVOTAL study: a randomized comparison of endovascular repair versus surveillance in patients with smaller abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16130206" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Comparison of surveillance vs Aortic Endografting for Small Aneurysm Repair (CAESAR) trial: study design and progress.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32609382" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Surgery for small asymptomatic abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17514693" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Final 12-year follow-up of surgery versus surveillance in the UK Small Aneurysm Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25159236" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Effect of age on survival between open repair and surveillance for small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19118733" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Fit patients with small abdominal aortic aneurysms (AAAs) do not benefit from early intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12000814" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Long-term outcomes of immediate repair compared with surveillance of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23562339" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Economic analysis of endovascular repair versus surveillance for patients with small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28742684" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : Endovascular Repair of Abdominal Aortic Aneurysm in Patients Physically Ineligible for Open Repair: Very Long-term Follow-up in the EVAR-2 Randomized Controlled Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15978926" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Endovascular aneurysm repair and outcome in patients unfit for open repair of abdominal aortic aneurysm (EVAR trial 2): randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30636430" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Safety of Men With Small and Medium Abdominal Aortic Aneurysms Under Surveillance in the NAAASP.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24530712" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Payer status, preoperative surveillance, and rupture of abdominal aortic aneurysms in the US Medicare population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22079461" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Socioeconomic position, comorbidity, and mortality in aortic aneurysms: a 13-year prospective cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12170209" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Ruptured abdominal aortic aneurysm in a well-defined geographic area.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25621354" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : Trans-Atlantic debate: Whether evidence supports reducing the threshold diameter to 5 cm for elective interventions in women with abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11496273" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Influence of diagnostic criteria on the prevalence of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31403186" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Sex differences in repair rates and outcomes of patients with ruptured abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30395361" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Sex differences in national rates of repair of emergency abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21658895" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : The influence of gender and aortic aneurysm size on eligibility for endovascular abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27520304" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Sex-related trends in mortality after elective abdominal aortic aneurysm surgery between 2002 and 2013 at National Health Service hospitals in England: less benefit for women compared with men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23403220" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : The natural course of abdominal aortic aneurysms that meet the treatment criteria but not the operative requirements.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20564307" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Systematic review and meta-analysis of sex differences in outcome after intervention for abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27374814" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : Late Survival in Nonoperated Patients with Infrarenal Abdominal Aortic Aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24001483" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Immediate open repair vs surveillance in patients with small abdominal aortic aneurysms: survival differences by aneurysm size.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28745403" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Sex differences in mortality after abdominal aortic aneurysm repair in the UK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28455148" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : Morphological suitability for endovascular repair, non-intervention rates, and operative mortality in women and men assessed for intact abdominal aortic aneurysm repair: systematic reviews with meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24388278" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Relative importance of aneurysm diameter and body size for predicting abdominal aortic aneurysm rupture in men and women.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11923615" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Variation in death rate after abdominal aortic aneurysmectomy in the United States: impact of hospital volume, gender, and age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18575028" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Should abdominal aortic aneurysm be managed differently in women?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22322123" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Women derive less benefit from elective endovascular aneurysm repair than men.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17502634" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Systematic review: repair of unruptured abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26116489" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Systematic Review and Meta-analysis of Long-term survival After Elective Infrarenal Abdominal Aortic Aneurysm Repair 1969-2011: 5 Year Survival Remains Poor Despite Advances in Medical Care and Treatment Strategies.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26200979" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Long-Term Outcomes of Abdominal Aortic Aneurysm in the Medicare Population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24704051" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : Elective EVAR in nonagenarians is safe in carefully selected patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24530722" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Results of F-EVAR in octogenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22863795" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Age-stratified results from 20,095 aortoiliac aneurysm repairs: should we approach octogenarians and nonagenarians differently?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25461753" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Abdominal aortic aneurysm repair in nonagenarians.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24084274" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : Elective treatment of abdominal aortic aneurysm is reasonable in patients&gt;85 years of age.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25312534" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Frailty increases the risk of 30-day mortality, morbidity, and failure to rescue after elective abdominal aortic aneurysm repair independent of age and comorbidities.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26631772" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Morphology of Small Abdominal Aortic Aneurysms Should be Considered before Continued Ultrasound Surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15210603" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Abdominal aortic aneurysm expansion: risk factors and time intervals for surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17027302" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : Medical optimisation can reduce morbidity and mortality associated with elective aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22304861" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Preoperative cardiac evaluation and perioperative cardiac therapy in patients undergoing open surgery for abdominal aortic aneurysms: effects on cardiovascular outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11177330" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Cardiovascular disease and mortality in older adults with small abdominal aortic aneurysms detected by ultrasonography: the cardiovascular health study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26115925" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : The prevalence of abdominal aortic aneurysm is consistently high among patients with coronary artery disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19066005" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Prevalence of risk factors, coronary and systemic atherosclerosis in abdominal aortic aneurysm: comparison with high cardiovascular risk population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15483279" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : A randomized trial comparing conventional and endovascular repair of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20382983" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Endovascular versus open repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19826022" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Outcomes following endovascular vs open repair of abdominal aortic aneurysm: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27189132" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : A Meta-Analysis of the Association of Chronic Obstructive Pulmonary Disease with Abdominal Aortic Aneurysm Presence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22178250" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : What are the risk factors for renal failure following open elective abdominal aortic aneurysm repair?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20395842" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Renal function and abdominal aortic aneurysm (AAA): the impact of different management strategies on long-term renal function in the UK EndoVascular Aneurysm Repair (EVAR) Trials.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15710776" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Thoracic and abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24246537" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Gaps in preoperative surveillance and rupture of abdominal aortic aneurysms among Medicare beneficiaries.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26474507" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Surveillance outcomes of small abdominal aortic aneurysms identified from a large screening program.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/203" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Responsiveness of neurogenic hearts to octopamine.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22389113" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Meta-analysis of individual patient data to examine factors affecting growth and rupture of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23443444" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Surveillance intervals for small abdominal aortic aneurysms: a meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22128040" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Surveillance strategies according to the rate of growth of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19962261" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Clinical validation of a software for quantitative follow-up of abdominal aortic aneurysm maximal diameter and growth by CT angiography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21035700" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Post-endovascular aneurysm repair patient outcomes and follow-up are not adversely impacted by long travel distance to tertiary vascular surgery centers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18456596" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : Screening for aortic aneurysm: Detection is not as harmful as it might seem.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9357459" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Relationship of age, gender, race, and body size to infrarenal aortic diameter. The Aneurysm Detection and Management (ADAM) Veterans Affairs Cooperative Study Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12443589" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23806259" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : The role of diameter versus volume as the best prognostic measurement of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21316893" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Aortic volume as an indicator of disease progression in patients with untreated infrarenal abdominal aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21601403" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Measurements and detection of abdominal aortic aneurysm growth: Accuracy and reproducibility of a segmentation software.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21304070" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Abdominal aortic aneurysm growth predicted by uptake of ultrasmall superparamagnetic particles of iron oxide: a pilot study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28720724" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Aortic Wall Inflammation Predicts Abdominal Aortic Aneurysm Expansion, Rupture, and Need for Surgical Repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25932334" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : MRI using ultrasmall superparamagnetic particles of iron oxide in patients under surveillance for abdominal aortic aneurysms to predict rupture or surgical repair: MRI for abdominal aortic aneurysms to predict rupture or surgery-the MA(3)RS study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20869889" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging of abdominal aortic aneurysms--a feasibility study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26763279" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Novel Molecular Imaging Approaches to Abdominal Aortic Aneurysm Risk Stratification.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27283346" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Inflammation as a Predictor of Abdominal Aortic Aneurysm Growth and Rupture: A Systematic Review of Imaging Biomarkers.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26919936" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Positron Emission Tomography and Magnetic Resonance Imaging of Cellular Inflammation in Patients with Abdominal Aortic Aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26041641" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Iron-induced myocardial injury: an alarming side effect of superparamagnetic iron oxide nanoparticles.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18729562" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : In vivo imaging of abdominal aortic aneurysms: increased FDG uptake suggests inflammation in the aneurysm wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30228233" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Antithrombotic therapy in abdominal aortic aneurysm: beneficial or detrimental?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8270083" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Aortic aneurysm leak after streptokinase treatment for myocardial infarction.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31235491" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Aortic stent graft leak and aneurysm rupture after alteplase for stroke.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33404647" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Association of Fluoroquinolone Use With Short-term Risk of Development of Aortic Aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28739200" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Aortic Dissection and Aortic Aneurysms Associated with Fluoroquinolones: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32897307" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Association of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32897358" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Association of Infections and Use of Fluoroquinolones With the Risk of Aortic Aneurysm or Aortic Dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33091293" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33091293" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Fluoroquinolones and the Risk of Aortopathy: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/37724037" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Lack of association between fluoroquinolone and aortic aneurysm or dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24046399" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Designation as "unfit for open repair" is associated with poor outcomes after endovascular aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26371412" id="rid116" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>117 : Outcome in Men with a Screen-detected Abdominal Aortic Aneurysm Who are not Fit for Intervention.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21900095" id="rid117" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>118 : The rise and fall of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12052126" id="rid118" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>119 : Rupture rate of large abdominal aortic aneurysms in patients refusing or unfit for elective repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23158576" id="rid119" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>120 : Palliation of abdominal aortic aneurysms in the endovascular era.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25661721" id="rid120" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>121 : Rupture rates of untreated large abdominal aortic aneurysms in patients unfit for elective repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21254006" id="rid121" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>122 : Systematic review and meta-analysis of the effects of statin therapy on abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27704527" id="rid122" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>123 : Cardiovascular risk prevention and all-cause mortality in primary care patients with an abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27666804" id="rid123" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>124 : Management of Modifiable Vascular Risk Factors Improves Late Survival following Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20473995" id="rid124" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>125 : Long-term benefit and cost-effectiveness analysis of screening for abdominal aortic aneurysms from a randomized controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32928667" id="rid125" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>126 : Editor's Choice - Effect of Statins on Total Mortality in Abdominal Aortic Aneurysm Repair: A Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24144736" id="rid126" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>127 : Statin therapy is associated with improved survival after endovascular and open aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17398372" id="rid127" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>128 : Randomized trial of the effects of cholesterol-lowering with simvastatin on peripheral vascular and other major vascular outcomes in 20,536 people with peripheral arterial disease and other high-risk conditions.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19651061" id="rid128" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>129 : Prehospital HMG Co-A reductase inhibitor use and reduced mortality in ruptured abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21178671" id="rid129" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>130 : Impact of preoperative statin therapy on adverse postoperative outcomes in patients undergoing vascular surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14715323" id="rid130" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>131 : Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20382494" id="rid131" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>132 : Preoperative statin therapy is associated with improved outcomes and resource utilization in patients undergoing aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18690591" id="rid132" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>133 : Statins are associated with decreased mortality in abdominal, but not in thoracic aortic aneurysm patients undergoing endovascular repair: propensity score-adjusted analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18922711" id="rid133" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>134 : Long-term cardiac outcome in high-risk patients undergoing elective endovascular or open infrarenal abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16849016" id="rid134" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>135 : Statin use is associated with reduced all-cause mortality after endovascular abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16794911" id="rid135" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>136 : Cardiac medical therapy among patients undergoing abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15350554" id="rid136" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>137 : A combination of statins and beta-blockers is independently associated with a reduction in the incidence of perioperative mortality and nonfatal myocardial infarction in patients undergoing abdominal aortic aneurysm surgery.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24797553" id="rid137" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>138 : Impact of statin therapy on patients with coronary heart disease and aortic aneurysm or dissection.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16442379" id="rid138" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>139 : Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20630687" id="rid139" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>140 : Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18391122" id="rid140" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>141 : Medical management of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10826454" id="rid141" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>142 : The aneurysm detection and management study screening program: validation cohort and final results. Aneurysm Detection and Management Veterans Affairs Cooperative Study Investigators.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19364978" id="rid142" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>143 : Risk factors for abdominal aortic aneurysms: a 7-year prospective study: the TromsøStudy, 1994-2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10587395" id="rid143" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>144 : The association between cigarette smoking and abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12891116" id="rid144" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>145 : Smokers' relative risk for aortic aneurysm compared with other smoking-related diseases: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21959305" id="rid145" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>146 : 2011 ACCF/AHA Focused Update of the Guideline for the Management of patients with peripheral artery disease (Updating the 2005 Guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15555973" id="rid146" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>147 : Accelerated enlargement of experimental abdominal aortic aneurysms in a mouse model of chronic cigarette smoke exposure.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10493476" id="rid147" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>148 : Risk factors for aneurysm rupture in patients kept under ultrasound surveillance. UK Small Aneurysm Trial Participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10873733" id="rid148" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>149 : Smoking, lung function and the prognosis of abdominal aortic aneurysm. The UK Small Aneurysm Trial Participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2787456" id="rid149" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>150 : Role of preoperative cessation of smoking and other factors in postoperative pulmonary complications: a blinded prospective study of coronary artery bypass patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19786250" id="rid150" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>151 : The care of patients with an abdominal aortic aneurysm: the Society for Vascular Surgery practice guidelines.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17182926" id="rid151" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>152 : AAA disease: mechanism, stratification, and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29210916" id="rid152" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>153 : Acute Inflammatory Responses to Exercise in Patients with Abdominal Aortic Aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12482828" id="rid153" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>154 : Flow loading induces macrophage antioxidative gene expression in experimental aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20099356" id="rid154" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>155 : Quantifying in vivo hemodynamic response to exercise in patients with intermittent claudication and abdominal aortic aneurysms using cine phase-contrast MRI.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23793234" id="rid155" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>156 : A randomized trial of exercise training in abdominal aortic aneurysm disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20724934" id="rid156" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>157 : Effects of exercise training in patients with abdominal aortic aneurysm: preliminary results from a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32453369" id="rid157" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>158 : Effect of Doxycycline on Aneurysm Growth Among Patients With Small Infrarenal Abdominal Aortic Aneurysms: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27641464" id="rid158" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>159 : Challenges and opportunities in limiting abdominal aortic aneurysm growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21330159" id="rid159" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>160 : Pharmacological interventions to attenuate the expansion of abdominal aortic aneurysm (AAA) - a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21596379" id="rid160" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>161 : Current status of medical management for abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22972146" id="rid161" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>162 : Medical treatment for small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22854530" id="rid162" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>163 : Medical treatment of small abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26482507" id="rid163" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>164 : Editor's Choice - Pharmaceutical Management of Small Abdominal Aortic Aneurysms: A Systematic Review of the Clinical Evidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26331269" id="rid164" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>165 : Multicentre study of abdominal aortic aneurysm measurement and enlargement.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11802135" id="rid165" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>166 : Propranolol for small abdominal aortic aneurysms: results of a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7909340" id="rid166" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>167 : Abdominal aortic aneurysm expansion rate: effect of size and beta-adrenergic blockade.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2704229" id="rid167" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>168 : Propranolol stimulates the crosslinking of matrix components in skin from the aneurysm-prone blotchy mouse.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2895995" id="rid168" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>169 : Effect of beta-adrenergic blockade on the growth rate of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid169" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>170 : Effect of propanolol on the expansion of abdominal aortic aneurysms: a randomized study</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10392481" id="rid170" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>171 : Impaired results of a randomised double blinded clinical trial of propranolol versus placebo on the expansion rate of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17884087" id="rid171" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>172 : Molecular mechanism of imidapril for cardiovascular protection via inhibition of MMP-9.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14596367" id="rid172" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>173 : Effects of losartan and enalapril at different doses on cardiac and renal interstitial matrix in spontaneously hypertensive rats.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29175038" id="rid173" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>174 : Renin-angiotensin system blockade does not attenuate abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12855482" id="rid174" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>175 : Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10841519" id="rid175" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>176 : Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19252100" id="rid176" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>177 : ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19556720" id="rid177" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>178 : Involvement of vascular angiotensin II-forming enzymes in the progression of aortic abdominal aneurysms in angiotensin II- infused ApoE-deficient mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11331849" id="rid178" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>179 : Suppression of experimental abdominal aortic aneurysms in the rat by treatment with angiotensin-converting enzyme inhibitors.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20189193" id="rid179" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>180 : Effectiveness of combination of losartan potassium and doxycycline versus single-drug treatments in the secondary prevention of thoracic aortic aneurysm in Marfan syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19008714" id="rid180" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>181 : Telmisartan prevents aneurysm progression in the rat by inhibiting proteolysis, apoptosis and inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19020766" id="rid181" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>182 : Inhibition of experimental abdominal aortic aneurysm in a rat model by the angiotensin receptor blocker valsartan.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16601194" id="rid182" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>183 : Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15585195" id="rid183" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>184 : Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16920471" id="rid184" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>185 : Angiotensin-converting enzyme inhibitors and aortic rupture: a population-based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20620765" id="rid185" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>186 : An analysis of drug modulation of abdominal aortic aneurysm growth through 25 years of surveillance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20494541" id="rid186" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>187 : Use of angiotensin converting enzyme inhibitors is associated with increased growth rate of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27371719" id="rid187" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>188 : An evaluation of the effect of an angiotensin-converting enzyme inhibitor on the growth rate of small abdominal aortic aneurysms: a randomized placebo-controlled trial (AARDVARK).</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32845283" id="rid188" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>189 : Efficacy of Telmisartan to Slow Growth of Small Abdominal Aortic Aneurysms: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668331" id="rid189" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>190 : Pathogenesis of abdominal aortic aneurysms: a multidisciplinary research program supported by the National Heart, Lung, and Blood Institute.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12096274" id="rid190" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>191 : A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17574455" id="rid191" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>192 : Simvastatin attenuates the activity of matrix metalloprotease-9 in aneurysmal aortic tissue.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16414398" id="rid192" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>193 : Simvastatin suppresses experimental aortic aneurysm expansion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19506106" id="rid193" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>194 : Rosiglitazone reduces the development and rupture of experimental aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19729613" id="rid194" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>195 : Simvastatin inhibits angiotensin II-induced abdominal aortic aneurysm formation in apolipoprotein E-knockout mice: possible role of ERK.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15621996" id="rid195" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>196 : Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20809215" id="rid196" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>197 : Efficacy of simvastatin in reducing aortic dilatation in mouse models of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18482727" id="rid197" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>198 : Inhibition of development of experimental aortic abdominal aneurysm in rat model by atorvastatin through inhibition of macrophage migration.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24849021" id="rid198" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>199 : Statin use and rupture of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16520071" id="rid199" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>200 : Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20152231" id="rid200" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>201 : Association of statin prescription with small abdominal aortic aneurysm progression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19119028" id="rid201" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>202 : Expansion of small-diameter abdominal aortic aneurysms is not reflected by the release of inflammatory mediators IL-6, MMP-9 and CRP in plasma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18430763" id="rid202" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>203 : The use of statins and fate of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18440183" id="rid203" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>204 : Growth predictors and prognosis of small abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20880729" id="rid204" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>205 : A randomised placebo-controlled double-blind trial to evaluate lipid-lowering pharmacotherapy on proteolysis and inflammation in abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20889295" id="rid205" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>206 : A randomized placebo controlled trial of the effect of preoperative statin use on matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in areas of low and peak wall stress in patients undergoing elective open repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20638223" id="rid206" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>207 : A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27106243" id="rid207" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>208 : Metformin treatment status and abdominal aortic aneurysm disease progression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30197158" id="rid208" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>209 : Metformin prescription status and abdominal aortic aneurysm disease progression in the U.S. veteran population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30936409" id="rid209" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>210 : Metformin prescription and aortic aneurysm: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28650557" id="rid210" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>211 : Association between metformin prescription and growth rates of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18728038" id="rid211" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>212 : Low-dose aspirin may prevent growth and later surgical repair of medium-sized abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18414871" id="rid212" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>213 : Measurement and determinants of infrarenal aortic thrombus volume.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20530504" id="rid213" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>214 : Evaluation of the diagnostic and prognostic value of plasma D-dimer for abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19047592" id="rid214" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>215 : Circulating markers of abdominal aortic aneurysm presence and progression.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19201759" id="rid215" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>216 : Mediators of neutrophil recruitment in human abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16507915" id="rid216" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>217 : Renewal of mural thrombus releases plasma markers and is involved in aortic abdominal aneurysm evolution.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19028049" id="rid217" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>218 : Effect of blocking platelet activation with AZD6140 on development of abdominal aortic aneurysm in a rat aneurysmal model.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1700620" id="rid218" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>219 : Human abdominal aortic aneurysms. Immunophenotypic analysis suggesting an immune-mediated response.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7955258" id="rid219" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>220 : Cytokines that activate proteolysis are increased in abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19307471" id="rid220" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>221 : Complement-dependent neutrophil recruitment is critical for the development of elastase-induced abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22042930" id="rid221" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>222 : Immunosuppression and the abdominal aortic aneurysm: Doctor Jekyll or Mister Hyde?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19720934" id="rid222" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>223 : Critical role of mast cell chymase in mouse abdominal aortic aneurysm formation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17932568" id="rid223" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>224 : Mast cells modulate the pathogenesis of elastase-induced abdominal aortic aneurysms in mice.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19515525" id="rid224" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>225 : Mast cells associate with neovessels in the media and adventitia of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25963302" id="rid225" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>226 : Randomized clinical trial of mast cell inhibition in patients with a medium-sized abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11496270" id="rid226" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>227 : Indicators of infection with Chlamydia pneumoniae are associated with expansion of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11488791" id="rid227" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>228 : Randomized double-blind controlled trial of roxithromycin for prevention of abdominal aortic aneurysm expansion.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19640922" id="rid228" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>229 : Intermittent roxithromycin for preventing progression of small abdominal aortic aneurysms: long-term results of a small clinical trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19364980" id="rid229" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>230 : Clinical trial of doxycycline for matrix metalloproteinase-9 inhibition in patients with an abdominal aneurysm: doxycycline selectively depletes aortic wall neutrophils and cytotoxic T cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19216971" id="rid230" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>231 : Presidential address: Time to lead!</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14681644" id="rid231" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>232 : Mechanism of inhibition of matrix metalloproteinase-2 expression by doxycycline in human aortic smooth muscle cells.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10664501" id="rid232" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>233 : Preoperative treatment with doxycycline reduces aortic wall expression and activation of matrix metalloproteinases in patients with abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12096249" id="rid233" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>234 : Prolonged administration of doxycycline in patients with small asymptomatic abdominal aortic aneurysms: report of a prospective (Phase II) multicenter study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8637112" id="rid234" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>235 : Doxycycline inhibition of aneurysmal degeneration in an elastase-induced rat model of abdominal aortic aneurysm: preservation of aortic elastin associated with suppressed production of 92 kD gelatinase.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15297830" id="rid235" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>236 : Rapamycin suppresses experimental aortic aneurysm growth.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24629569" id="rid236" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>237 : Rapamycin limits the growth of established experimental abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24490266" id="rid237" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>238 : Doxycycline for stabilization of abdominal aortic aneurysms: a randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27018941" id="rid238" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>239 : Non-invasive Treatment of Abdominal Aortic Aneurysm Clinical Trial (N-TA(3)CT): Design of a Phase IIb, placebo-controlled, double-blind, randomized clinical trial of doxycycline for the reduction of growth of small abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10848851" id="rid239" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>240 : Risk factors for postoperative death following elective surgical repair of abdominal aortic aneurysm: results from the UK Small Aneurysm Trial. On behalf of the UK Small Aneurysm Trial participants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16520153" id="rid240" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>241 : Improving aneurysm-related outcomes: nationwide benefits of endovascular repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14981436" id="rid241" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>242 : Perioperative outcomes after open and endovascular repair of intact abdominal aortic aneurysms in the United States during 2001.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9158126" id="rid242" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>243 : Comparison of transperitoneal and retroperitoneal approaches for infrarenal aortic surgery: early and late results.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30883709" id="rid243" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>244 : Meta-analysis of long-term survival after elective endovascular or open repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28160528" id="rid244" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>245 : Meta-analysis of individual-patient data from EVAR-1, DREAM, OVER and ACE trials comparing outcomes of endovascular or open repair for abdominal aortic aneurysm over 5 years.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21484775" id="rid245" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>246 : Incidence of cardiovascular events and death after open or endovascular repair of abdominal aortic aneurysm in the randomized EVAR trial 1.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15944424" id="rid246" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>247 : Two-year outcomes after conventional or endovascular repair of abdominal aortic aneurysms.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20484396" id="rid247" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>248 : Long-term outcome of open or endovascular repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15978925" id="rid248" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>249 : Endovascular aneurysm repair versus open repair in patients with abdominal aortic aneurysm (EVAR trial 1): randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21276681" id="rid249" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>250 : A randomized controlled trial of endovascular aneurysm repair versus open surgery for abdominal aortic aneurysms in low- to moderate-risk patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23171095" id="rid250" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>251 : Long-term comparison of endovascular and open repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24453068" id="rid251" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>252 : Endovascular repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23475697" id="rid252" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>253 : Systematic review and meta-analysis of the early and late outcomes of open and endovascular repair of abdominal aortic aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23358266" id="rid253" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>254 : Vascular disease: Repair of infrarenal aortic aneurysm--the debate is OVER.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18234751" id="rid254" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>255 : Endovascular vs. open repair of abdominal aortic aneurysms in the Medicare population.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27743617" id="rid255" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>256 : Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27743617" id="rid256" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>257 : Endovascular versus open repair of abdominal aortic aneurysm in 15-years' follow-up of the UK endovascular aneurysm repair trial 1 (EVAR trial 1): a randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20008689" id="rid257" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>258 : Projected cancer risks from computed tomographic scans performed in the United States in 2007.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31141634" id="rid258" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>259 : Open versus Endovascular Repair of Abdominal Aortic Aneurysm.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23254440" id="rid259" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>260 : Meta-analysis of prospective trials determining the short- and mid-term effect of elective open and endovascular repair of abdominal aortic aneurysms on quality of life.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21820922" id="rid260" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>261 : Elective endovascular vs. open repair for abdominal aortic aneurysm in patients aged 80 years and older: systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26403831" id="rid261" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>262 : Endovascular vs Open Aneurysm Repair in the Young: Systematic Review and Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24824839" id="rid262" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>263 : Outcome of open versus endovascular abdominal aortic aneurysm repair in obese patients: a systemic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24824839" id="rid263" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>264 : Outcome of open versus endovascular abdominal aortic aneurysm repair in obese patients: a systemic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24200131" id="rid264" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>265 : Mini-invasive treatment of abdominal aortic aneurysms: current roles of endovascular, laparoscopic, and open techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23642927" id="rid265" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>266 : Optimal selection of patients for elective abdominal aortic aneurysm repair based on life expectancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27592036" id="rid266" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>267 : Meta-analysis of Outcomes Following Aneurysm Repair in Patients with Synchronous Intra-abdominal Malignancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/36597592" id="rid267" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>268 : Elective Endovascular vs Open Repair for Elective Abdominal Aortic Aneurysm in Patients≥80 years of Age: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24957410" id="rid268" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>269 : Comparative safety of endovascular and open surgical repair of abdominal aortic aneurysms in low-risk male patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24280332" id="rid269" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>270 : Debate: whether young, good-risk patients should be treated with endovascular abdominal aortic aneurysm repair.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24239144" id="rid270" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>271 : What is the best option for elective repair of an abdominal aortic aneurysm in a young fit patient?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25457459" id="rid271" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>272 : Durability and survival are similar after elective endovascular and open repair of abdominal aortic aneurysms in younger patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27138354" id="rid272" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>273 : Comparison of outcomes after endovascular and open repair of abdominal aortic aneurysms in low-risk patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27627802" id="rid273" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>274 : Long-term Cost-effectiveness in the Veterans Affairs Open vs Endovascular Repair Study of Aortic Abdominal Aneurysm: A Randomized Clinical Trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27784712" id="rid274" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>275 : Variations in Abdominal Aortic Aneurysm Care: A Report From the International Consortium of Vascular Registries.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
